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 (c) Analyses information provided by Governments, United Nations bodies, specialized agencies or other 
competent international organizations, with a view to ensuring that the provisions of the international drug control 
treaties are adequately carried out by Governments, and recommends remedial measures; 
 (d) Maintains a permanent dialogue with Governments to assist them in complying with their obligations under 
the international drug control treaties and, to that end, recommends, where appropriate, technical or financial assistance 
to be provided. 
 INCB is called upon to ask for explanations in the event of apparent violations of the treaties, to propose 
appropriate remedial measures to Governments that are not fully applying the provisions of the treaties or are 
encountering difficulties in applying them and, where necessary, to assist Governments in overcoming such difficulties. 
If, however, INCB notes that the measures necessary to remedy a serious situation have not been taken, it may call the 
matter to the attention of the parties concerned, the Commission on Narcotic Drugs and the Economic and Social 
Council. As a last resort, the treaties empower INCB to recommend to parties that they stop importing drugs from a 
defaulting country, exporting drugs to it or both. In all cases, INCB acts in close cooperation with Governments. 
 INCB assists national administrations in meeting their obligations under the conventions. To that end, it proposes 
and participates in regional training seminars and programmes for drug control administrators. 
  
Reports 
  
 The international drug control treaties require INCB to prepare an annual report on its work. The annual report 
contains an analysis of the drug control situation worldwide so that Governments are kept aware of existing and 
potential situations that may endanger the objectives of the international drug control treaties. INCB draws the 
attention of Governments to gaps and weaknesses in national control and in treaty compliance; it also makes 
suggestions and recommendations for improvements at both the national and international levels. The annual report is 
based on information provided by Governments to INCB, United Nations entities and other organizations. It also uses 
information provided through other international organizations, such as INTERPOL and the World Customs 
Organization, as well as regional organizations. 
 The annual report of INCB is supplemented by detailed technical reports. They contain data on the licit 
movement of narcotic drugs and psychotropic substances required for medical and scientific purposes, together with an 
analysis of those data by INCB. Those data are required for the proper functioning of the system of control over the 
licit movement of narcotic drugs and psychotropic substances, including preventing their diversion to illicit channels. 
Moreover, under the provisions of article 12 of the 1988 Convention, INCB reports annually to the Commission on 
Narcotic Drugs on the implementation of that article. That report, which gives an account of the results of the 
monitoring of precursors and of the chemicals frequently used in the illicit manufacture of narcotic drugs and 
psychotropic substances, is also published as a supplement to the annual report. 
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  Foreword 
 
 
When Governments come together and engage in finding solutions to common 
problems, answers arise and success is achieved. International cooperation in the 
area of precursor control is no exception. It is my pleasure to present the  
2009 report of the International Narcotics Control Board on precursors, which 
contains an account of those determined actions that have restrained criminal 
operations by reducing the availability of chemicals for illicit drug manufacture.  
 International collaborative initiatives enabled by the Board have allowed 
Governments to exchange data on trade, diversions and seizures. This has translated 
into increasing seizures of acetic anhydride, more effective monitoring of suspicious 
transactions and the identification of trafficking trends and networks. 
 Countries are responding to the menace of chemical diversion and following 
the Board’s recommendations by strengthening precursor controls. For example, in 
2009, several Governments introduced new regulations to limit the availability of 
ephedrine and pseudoephedrine in their territories. 
 However, traffickers keep finding new ways to fuel their illegal operations. 
Despite the significant decline in attempts to divert raw ephedrine and 
pseudoephedrine, the two precursors continue to be trafficked, but now, increasingly 
in the form of pharmaceutical preparations. The diversion routes are rapidly 
changing, and new countries are being targeted by criminals.  
 The number and the magnitude of drug-manufacturing facilities seized in some 
regions are a grim illustration of this reality. Traffickers are fast adapting to the 
restrictions and are modifying their processes as they seek out non-scheduled 
chemical substances. To achieve their insidious ends, criminal organizations do not 
hesitate to perpetrate tremendous amounts of violence, threatening security in many 
countries. Thus, the international community cannot afford to waver in its 
commitment to stop trafficking in precursor chemicals. 
 The lessons of the past have shown us that collective efforts can indeed 
achieve positive results. The approaches taken to stop the flow of precursor 
chemicals for heroin production can be applied to combat the trafficking of 
chemicals used in the illicit manufacture of cocaine. This report offers us the 
opportunity to asses the accomplishments, move forward with the experience 
acquired and overcome the remaining challenges. 
 The Board invites Governments to seize this unique opportunity to tackle the 
scourge of drug abuse starting at its origins and continue cooperating in the area of 
precursor chemical control.  
           
Sevil Atasoy 
President 
International Narcotics Control Board 
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  Preface 
 
 
The United Nations Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 provides, inter alia, that the International 
Narcotics Control Board shall report annually to the Commission on Narcotic Drugs 
on the implementation of article 12 of the Convention and that the Commission 
shall periodically review the adequacy and propriety of Tables I and II of the 
Convention.  
 In addition to its annual report and other technical publications (on narcotic 
drugs and psychotropic substances), the Board has decided to publish its report on 
the implementation of article 12 of the 1988 Convention, in accordance with the 
following provisions contained in article 23 of the Convention: 
  “1. The Board shall prepare an annual report on its work containing an 
analysis of the information at its disposal and, in appropriate cases, an account 
of the explanations, if any, given by or required of Parties, together with any 
observations and recommendations which the Board desires to make. The 
Board may make such additional reports as it considers necessary. The reports 
shall be submitted to the [Economic and Social] Council through the 
Commission which may make such comments as it sees fit. 
  “2. The reports of the Board shall be communicated to the Parties and 
subsequently published by the Secretary 
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Explanatory notes 
 
The following abbreviations have been used in this report: 
MDMA methylenedioxymethamphetamine 
3,4-MDP-2-P 3,4-methylenedioxyphenyl-2-propanone 
P-2-P 1-phenyl-2-propanone 
PEN Online Pre-Export Notification Online 
 The designations employed and the presentation of the material in this 
publication do not imply the expression of any opinion whatsoever on the part of the 
Secretariat of the United Nations concerning the legal status of any country, 
territory, city or area or of its authorities, or concerning the delimitation of its 
frontiers or boundaries.  
 Countries and areas are referred to by the names that were in official use at the 
time the relevant data were collected. 
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 Summary 
With Namibia becoming party to the United Nations Convention against Illicit 
Traffic in Narcotic Drugs and Psychotropic Substances of 1988, the number of States 
that have joined the treaty has risen to 183. The Board again calls on Equatorial 
Guinea, the Holy See, Kiribati, the Marshall Islands, Nauru, Palau, Papua New 
Guinea, the Solomon Islands, Somalia, Timor-Leste and Tuvalu to become parties to 
the Convention and thus ensure universal accession. 
 The Board notes the adoption of new regulations and the strengthening of 
existing precursor control measures in numerous countries. During the reporting 
period, such measures were introduced by Afghanistan, Argentina, China, Colombia, 
the Czech Republic, Guatemala, Jordan, Nicaragua, Panama, Peru, the Republic of 
Korea, the United Kingdom of Great Britain and Northern Ireland, the United States 
of America and Uruguay. 
 In response to stronger controls in many regions, traffickers have been forced 
to seek non-scheduled chemical substances for the illicit manufacture of drugs. The 
Board strongly encourages Governments to establish appropriate mechanisms to 
monitor the movement of non-scheduled substances and to prevent their use in the 
illicit manufacture of drugs. 
 In 2009, within the framework of the review of the possible transfer of 
phenylacetic acid from Table II to Table I of the Convention, the Board requested all 
Governments to provide updated information on the use of the substance in illicit 
drug manufacture. Responses received confirmed the initial concerns of the Board 
about the significance and extent of misuse of the chemical. Therefore, the Board has 
submitted a recommendation to the Commission on Narcotic Drugs for phenylacetic 
acid to be rescheduled. 
 The Board’s online system for the exchange of pre-export notifications (PEN 
Online) has become the main tool for the monitoring of international trade in 
scheduled chemicals and preventing diversion. The Board urges all Governments to 
follow the example of the 111 countries and territories that are currently registered 
with the system, comply with Security Council resolution 1817 (2008) in that regard 
and utilize PEN Online. 
 The Board notes that international cooperation in precursor control, such as 
Project Cohesion and Project Prism, has yielded positive results in reducing the 
availability of precursor chemicals used in the illicit manufacture of drugs. For 
example, there has been a significant increase in seizures of acetic anhydride, and 
Governments have exchanged information related to diversions and seizures, 
facilitating the following-up of suspicious transactions and backtracking 
investigations. The Board notes that, following the success of international 
collaborative exercises such as Operation Ice Block and Operation Dice, the task 
forces of the two operations have agreed to continue and expand global activities 
against the diversion of chemicals used in the illicit manufacture of amphetamine-
type stimulants (Operation Ice Block) and heroin (Operation Dice). The Board will 
continue to support those activities by serving as the international focal point for the 
exchange of information. 
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 The above-mentioned activities have also led to the identification of shifts in 
trafficking trends and enabled some remedial action. For example, data exchanged 
under Project Prism have revealed a significant decline in attempts to divert raw 
ephedrine and pseudoephedrine from international trade channels. Seventy per cent 
of all identified instances of suspicious shipments or diversions currently involve 
those substances in the form of pharmaceutical preparations. The diversion routes for 
those precursors have also changed, with the appearance of numerous intermediate 
countries importing raw ephedrine and pseudoephedrine, where they are used to 
make preparations and then shipped to destinations in the Americas. Many 
trafficking routes for smuggling raw ephedrine and pseudoephedrine into Central 
America with the ultimate destination of Mexico have involved trans-shipment 
through Europe, North America and, more frequently, Central and South American 
countries. The Board invites all Governments to support the Government of Mexico 
in its efforts against illicit methamphetamine manufacture, particularly through 
participation in activities under Project Prism. 
 Despite significant seizures of acetic anhydride in major trading countries, 
particularly in countries of the European Union and East Asia, the diversion of the 
substance from domestic distribution channels continues to pose a threat. Control 
measures over trade in acetic anhydride on the internal market of the European 
Union appear to be insufficient to prevent diversion. The appearance of African 
destinations, such as Djibouti, among the countries targeted by traffickers is cause 
for particular concern. The Board welcomes the decision of the Government of 
Afghanistan to prohibit the importation of acetic anhydride into its territory. 
Nevertheless, the Board urges Afghanistan to comply with its treaty obligations and 
furnish information on seizures of precursor chemicals. 
 The Board is concerned about the purported formulation of P-2-P into cleaning 
and disinfection products in West Asia, which presents a risk of diversion. The 
manufacture of 3,4-MDP-2-P, which is used in clandestine manufacture of MDMA, 
is now entirely illicit and its distribution is through smuggling. The Board strongly 
urges all Governments to adequately control the substances from which this key 
precursor may be produced, in particular safrole and piperonal. 
 Activities to counter the trafficking of chemicals used in the illicit manufacture 
of cocaine, in particular potassium permanganate, lag behind those activities 
targeting amphetamine-type stimulants and heroin precursors. The Board invites 
countries of South America to use the mechanisms of Project Cohesion and urgently 
devise specific strategies and activities to improve the understanding of the sources 
of chemicals used in cocaine manufacture and the related diversion patterns and 
trafficking trends. 
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 I. Introduction 
 
 
1. The present report provides an overview of action 
taken by Governments and the International Narcotics 
Control Board since the 2008 report on precursors1 to 
implement the provisions of article 12 of the United 
Nations Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988.2  
2. As in past years, chapter II of the report contains 
information on developments related to the scheduling 
of substances, accession to the 1988 Convention, the 
treaty-mandated furnishing of data to the Board and 
highlights of major changes to national control 
measures. Chapter II includes the latest information on 
the estimated annual legitimate requirements for 
precursors of amphetamine-type stimulants, a review 
of the functioning of the pre-export notification system 
and a snapshot of data furnished on licit trade in, uses 
of and requirements for precursors. A summary of the 
activities and results achieved under Project Cohesion 
and Project Prism, the international initiatives focusing 
on precursor chemicals used in the illicit manufacture 
of cocaine and heroin and of amphetamine-type 
stimulants, respectively, are also contained in  
chapter II. 
3. Chapter III provides a review of licit trade and 
significant trends in the trafficking of precursor 
chemicals by substance, using available information. 
Chapter III also contains an overview of the most 
important cases of diversion and attempted diversion. 
4. Chapter IV provides a summary of salient 
conclusions and recommendations. Those 
recommendations are presented to facilitate the 
necessary actions to be taken by Governments in order 
to prevent trafficking in precursor chemicals. 
5. The annexes to the present report contain 
practical information intended to assist competent 
authorities in carrying out their functions, including 
__________________ 
 1  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2008 on the Implementation of  
Article 12 of the United Nations Convention against 
Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 1988 (United Nations publication, Sales 
No. E.09.XI.4). 
 2  United Nations, Treaty Series, vol. 1582, No. 27627. 
information on the status of treaty adherence, the 
treaty-mandated submission of annual information by 
Governments and seizure data. 
 
 
 II. Action taken by Governments and 
by the Board  
 
 
 A. Scope of control  
 
 
6. Pursuant to Commission on Narcotic Drugs 
resolution 49/7, entitled “Promoting a consistent 
approach to the treatment of safrole-rich oils”, the 
Board formulated the following definition of safrole-
rich oils: “any mixtures or natural products containing 
safrole present in such a way that it can be used or 
recovered by readily applicable means”.3 The Board 
therefore reminds Governments of the definition of 
safrole and encourages them to control safrole-rich 
oils in the same manner as safrole. 
7. In response to the Board’s concern that current 
control measures for phenylacetic acid, a precursor for 
amphetamine-type stimulants, were not sufficient to 
prevent its diversion, in 2006 the Board convened a 
meeting of its advisory expert group to review the 
international movement of the substance. In 2007, in 
line with the recommendation made by the expert 
group, the Board sent a communication to the 
Secretary-General to formally initiate the procedures 
for the transfer of phenylacetic acid from Table II to 
Table I of the 1988 Convention. The Secretary-General 
invited Governments to express their opinion regarding 
the proposed rescheduling through a questionnaire that 
was prepared and distributed by the Commission on 
Narcotic Drugs. In 2008, the expert group reconvened 
to review the responses to the questionnaire and assess 
the level of global support for the rescheduling of 
phenylacetic acid. The expert group concluded that the 
available information supported the continuation of the 
procedures for the rescheduling of phenylacetic acid. 
8. In 2009, the Board requested Governments to 
provide updated information on the use of phenylacetic 
acid in the illicit manufacture of amphetamine-type 
__________________ 
 3  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2007 (United Nations publication, 
Sales No. E.08.XI.4), para. 5. 
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stimulants, including seizures of the substance, 
identification of the substance at illicit laboratory sites 
and forensic analysis identifying the substance in the 
synthesis of seized amphetamine-type stimulants. The 
Board is grateful to the 22 Governments that provided 
detailed responses to its questionnaire. Based on those 
responses, the initial concerns of the Board regarding 
the significance and the extent of the use of 
phenylacetic acid in the illicit manufacture of 
amphetamine-type stimulants have been confirmed. 
The Board has therefore submitted to the 
Commission on Narcotic Drugs a recommendation 
to transfer phenylacetic acid from Table II to  
Table I of the 1988 Convention. 
 
 
 B. Adherence to the 1988 Convention  
 
 
9. As at 31 October 2009, the 1988 Convention had 
been ratified, acceded to or approved by 183 States. 
Since the 2008 report of the Board on the 
implementation of article 12 was issued, Namibia has 
become a party to the Convention. The Board calls on 
the remaining 11 States (Equatorial Guinea, the 
Holy See, Kiribati, the Marshall Islands, Nauru, 
Palau, Papua New Guinea, the Solomon Islands, 
Somalia, Timor-Leste and Tuvalu) to implement the 
provisions of article 12 and to become parties to the 
Convention as soon as possible. 
10. The totals of accessions by region can be found in 
annex I to the present report. While all States in the 
Americas and most States in Africa, Asia and Europe 
are parties to the 1988 Convention, 7 of 15 States in 
Oceania have yet to become parties to the Convention. 
The recent cases of diversion of precursor chemicals in 
Oceania highlight the need for those remaining States 
to implement the provisions of article 12 and 
strengthen controls over precursor chemicals. 
 
 
 C. Reporting to the Board pursuant to 
article 12 of the 1988 Convention 
 
 
11. As at 31 October 2009, a total of 132 States and 
territories, as well as the European Commission (on 
behalf of the States Members of the United Nations 
that are members of the European Union), had 
submitted the annual questionnaire on substances 
frequently used in the illicit manufacture of narcotic 
drugs and psychotropic substances (form D) for 2008 
(see annex II for details). 
12. Angola submitted form D for the first time in 
2009, and Montenegro submitted form D for the first 
time in 2008. The Board welcomes the resumption of 
the submission of form D by Belize, Bhutan, Dominica 
and Iraq after a number of years of failing to do so. 
States parties to the 1988 Convention including 
Burundi, Gabon and the Gambia have never submitted 
form D. The Board urges those States parties to 
comply with their reporting obligations under the 
1988 Convention. 
13. Forty-seven Governments reported seizures of 
precursor chemicals on form D for 2008. Most reports 
by Governments provided only the frequency and 
quantities of substances in Tables I and II that were 
seized and did not provide details regarding methods of 
diversion and illicit manufacture, stopped shipments 
and seizures of substances not under international 
control. 
 
 
 D. Legislation and control measures 
 
 
14. In accordance with the provisions of article 12 of 
the 1988 Convention and the relevant resolutions of the 
General Assembly, the Economic and Social Council 
and the Commission on Narcotic Drugs, Governments 
are requested to adopt and implement national control 
measures to effectively monitor the movement of 
precursor chemicals. In addition, Governments are also 
requested to regularly review and take the steps 
necessary to strengthen existing precursor control 
measures should any weaknesses be identified. In line 
with the related recommendations, Governments have 
continued to establish or further tighten the national 
laws and regulations over the movement of precursors. 
15. The Board welcomes the decision of the 
Government of Afghanistan not to authorize any 
imports of acetic anhydride into its territory, since 
there is no legitimate use for the substance in the 
country. Therefore, the Board advises all countries 
that manufacture, trade in or export acetic 
anhydride not to export acetic anhydride to 
Afghanistan. 
16. In June 2008, Jordan introduced its instructions 
for the control of the import, export and handling of 
chemicals used for the manufacture of narcotics and 
   
 
3
 E/INCB/2009/4
psychotropic substances of 2008. Individual import or 
export permits for substances listed in Table I of the 
1988 Convention must be acquired from the Jordan 
Food and Drug Administration. Companies importing 
those substances must register and possess valid 
licenses and are required to keep trading records for at 
least two years and report annually to the competent 
authorities on the substances and quantities imported 
or exported. 
17. The Government of Argentina established the 
Interjurisdictional Committee of the National Register 
of Precursor Chemicals in December 2008. The 
Committee will coordinate the functions of the 
Register of Precursor Chemicals. In addition, 
according to a new resolution adopted in Argentina in 
2008, handlers of substances including lysergic acid, 
3,4-methylenedioxyphenyl-2-propanone (3,4-MDP-2-
P), 1 phenyl-2-propanone (P-2-P), ergotamine, 
ergometrine and phenylpropanolamine must be 
registered. 
18. In December 2008, Panama issued the Tables of 
Control and Surveillance, which include all  
23 substances listed in Tables I and II of the 
1988 Convention and certain substances in the Board’s 
limited international special surveillance list of non-
scheduled substances. Strict trading, import and export 
control measures are applied to the substances listed in 
the tables. For example, companies dealing in the 
controlled substances must register with the competent 
authorities of Panama, and an authorization or a 
certificate must be acquired for trading in those 
substances.  
19. In 2008, the Government of the United States of 
America modified the control measures for chemical 
mixtures containing ephedrine and pseudoephedrine. 
All chemical mixtures containing one of those 
substances, regardless of the concentration or form, are 
subject to the provisions of the Controlled Substances 
Act. Handlers of such chemical mixtures are required 
to register with the Drug Enforcement Administration 
and maintain their trading records. 
20. In 2008, the Government of the United Kingdom 
of Great Britain and Northern Ireland introduced 
stricter control measures on over-the-counter 
medicines containing ephedrine and pseudoephedrine. 
Under the new measures, it is illegal to sell or supply 
any product containing more than 720 milligrams of 
pseudoephedrine or 180 milligrams of ephedrine 
without a prescription. It is also illegal to sell or 
supply, in one transaction, a combination of products 
that, in total, contain more than 720 milligrams of 
pseudoephedrine or 180 milligrams of ephedrine. 
Moreover, it is also illegal to sell or supply in one 
transaction a product containing pseudoephedrine and a 
product containing ephedrine. 
21. Also in 2008, Peru strengthened control measures 
on the sale of cold medicines containing 
pseudoephedrine, which can now only be sold in 
pharmacies with prescriptions. Iceland has also 
introduced new measures prohibiting the sale of 
pharmaceutical preparations containing ephedrine. 
Import of the substance into Iceland is now permitted 
only with a special permit and is restricted to hospital 
use. 
22. In October 2008, the State Food and Drug 
Administration of China issued a notice on further 
strengthening control over compound preparations 
containing ephedrine. According to the notice, only 
qualified and authorized companies can trade in 
preparations containing ephedrine. Retail purchase 
shall be limited to five packages per purchase, and 
sales records must be kept for one year after the expiry 
date of the medicines. Domestic manufacturers are not 
allowed to manufacture for overseas customers, and the 
amount of raw materials used to manufacture 
preparations must be strictly controlled. The control 
measures do not apply to the Chinese traditional 
medicines containing ephedra.  
23. In Argentina, several new regulations were passed 
from August to December 2008 to strengthen the 
control of pharmaceutical preparations containing 
ephedrine and pseudoephedrine. The sale and use of 
pharmaceutical preparations containing ephedrine as 
their sole active ingredient are prohibited except in the 
form of injections that can be sold only for 
professional and hospital uses. The sale and use of 
pharmaceutical preparations containing ephedrine in 
combination with other active ingredients are allowed 
only for ophthalmic administration with prescription. It 
is prohibited to sell or use pharmaceutical preparations 
containing pseudoephedrine as their sole active 
ingredient, regardless of its concentration or 
pharmaceutical form. Pharmaceutical preparations 
containing pseudoephedrine in combination with other 
ingredients can be dispensed only with a prescription. 
Pharmacies and laboratories importing either of the 
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two substances must be registered and possess valid 
import authorizations. Unregistered laboratories, 
pharmacies and companies are not permitted to import 
ephedrine or pseudoephedrine.  
24. In Nicaragua, new control measures regarding 
ephedrine and pseudoephedrine were introduced in 
December 2008. Under the measures, it is prohibited to 
use ephedrine and pseudoephedrine in the manufacture 
of medicines or any other health products, except for 
the use of ephedrine or ephedrine sulphate in 
pharmaceutical injections. All import, distribution of or 
trade in ephedrine and pseudoephedrine is forbidden 
with certain exceptions. The acquisition or use of 
ephedrine is authorized only for research purposes. 
Stocks of raw materials or medicines containing 
ephedrine and pseudoephedrine were to be reported 
within 30 days of the publication of the resolution and 
be destroyed immediately. All ongoing imports were 
suspended immediately. 
25. According to a regulation on pseudoephedrine 
adopted by Guatemala in February 2009, the 
possession, synthesis, consumption, trade, storage, 
distribution and transportation within the national 
territory of any products containing pseudoephedrine is 
prohibited. The import of pseudoephedrine in the form 
of raw material or pharmaceutical preparation is also 
prohibited. 
26. In May 2009, the Czech Republic strengthened 
the control of the sale of pharmaceutical preparations 
containing pseudoephedrine to combat the increasing 
abuse of those products in illicit drug manufacture. 
According to the control measures, sales of 
pharmaceutical preparations containing pseudo-
ephedrine are restricted. Pharmacies selling the 
preparations must be electronically linked to the 
central registry of the State Institute for Drug Control. 
Pharmacies must enter the sales in the central registry 
to verify that the product has not already been sold to 
the individual that same week, in which case the 
transaction will not be allowed. Individuals wishing to 
purchase the product must present identification.  
27. In July 2009, the Government of Colombia 
adopted a resolution that prohibits the manufacture and 
import of and trade in all medicines containing 
pseudoephedrine and restricts trade in and use of 
ephedrine in such products. Stocks of those substances 
must be exhausted within 18 months of the entry into 
force of the resolution.  
28. In June 2009, El Salvador revoked its prohibition 
on the use of ephedrine in the manufacture of 
pharmaceutical preparations. The competent authorities 
are responsible for monitoring the movement of the 
substance and maintaining and updating a monthly 
record of authorized manufacturers and pharmacies. 
The Board invites the Government of El Salvador to 
continue its efforts to prevent the diversion of such 
preparations into illicit drug manufacture, in line with 
the efforts of most countries in the Americas.  
 
 
 E. Legitimate requirements for 
precursors of amphetamine-type 
stimulants 
 
 
29. In its resolution 49/3, the Commission on 
Narcotic Drugs, inter alia, requested Member States to 
provide to the Board annual estimates of their 
legitimate requirements for 3,4-MDP-2-P, ephedrine, 
pseudoephedrine and P-2-P, substances which are 
frequently used in the manufacture of amphetamine-
type stimulants. Pursuant to that resolution, as at 
31 October 2009, 120 Governments had provided those 
requirements to the Board and are contained in 
annex V to the present report. Those requirements are 
regularly updated and are available online 
(www.incb.org). The Board is pleased to note that 
Governments continue to consider the publishing of 
requirements to be a practical tool in preventing 
diversions. The Board requests Governments to 
review their requirements, as published, amend 
them as necessary and inform the Board of any 
changes required. 
30. The Board requested Governments to provide 
details of methodologies used in calculating annual 
estimates of their legitimate requirements for the four 
substances. While several countries have provided 
some information on methods used for such 
calculations, a number of countries have requested the 
Board to provide guidance on how to prepare such 
estimates. Based on a review of information provided 
by Governments, the Board has produced a document 
on issues that Governments may wish to consider when 
determining annual legitimate requirements for 
ephedrine and pseudoephedrine. The document was 
transmitted to all Governments in March 2009 and is 
also available on the website of the Board. 
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 F. Pre-export notifications 
 
 
31. While control and surveillance mechanisms for 
the legitimate trade in precursor chemicals are already 
in place in almost all major manufacturing, exporting 
and importing countries and trans-shipment points, 
many countries continued to strengthen their controls 
over precursor imports and exports in 2009. One of the 
most effective tools in the prevention of the diversion 
of precursor chemicals from international trade is the 
system for rapid information exchange through which 
the Governments of importing countries are made 
aware of exports of precursor chemicals destined for 
their territory, thus enabling them to verify the 
legitimacy of those transactions and to identify 
suspicious shipments. The Board is pleased to note the 
number of Governments that regularly submit pre-
export notifications for exports of substances listed in 
Table I and Table II, irrespective of whether or not they 
have been formally requested by importing 
Governments under article 12, paragraph 10 (a). The 
current list of Governments that have officially 
requested to receive pre-export notifications is 
provided in annex VI to the present report. 
32. The automated online system for the exchange of 
pre-export notifications (PEN Online), launched by the 
Board in March 2006, provides a mechanism for the 
real-time exchange of information between exporting 
and importing Governments regarding such shipment
notices. PEN Online is made available free of charge to 
all registered competent authorities and central national 
authorities responsible for sending and receiving pre-
export notifications. Currently, 111 countries and 
territories are authorized to access the PEN Online 
system (see the figure below). Seventy-six of those  
111 countries and territories, or 69 per cent, actively 
use the system on a daily basis. Approximately  
29,500 pre-export notifications have so far been sent to 
a total of 181 countries and territories via the PEN 
Online Internet portal. Further, the PEN Online system 
is being utilized with particular success in the 
international operations of the Board that address the 
diversion of some key chemicals used in the illicit 
manufacture of heroin, cocaine and amphetamine-type 
stimulants. However, the Board has noted that 
importing Governments do not always take immediate 
action upon receiving pre-export notifications to 
examine whether or not the transactions in question are 
legitimate. Even though countries are not obliged to 
respond to pre-export notifications, the Board 
recommends to any importing Government to 
provide feedback to the exporting country in the 
event that a transaction appears suspicious or 
additional time is required for checking. Under PEN 
Online, this “reply-to”-functionality is automatically 
provided. Importing Governments that have not yet 
done so are thus urged to register with the Board 
and utilize PEN Online. 
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Figure 
Countries and territories registered with the PEN Online system 
 
 
 G. Submission of data on licit trade in, 
uses of and requirements for 
precursors 
 
 
33. The Economic and Social Council, in its 
resolution 1995/20, requested Governments to provide, 
on a voluntary basis, data on their licit trade in, uses of 
and requirements for substances listed in Tables I  
and II of the 1988 Convention. Over the years, those 
data have proven to be crucial in assisting 
Governments in preventing diversions and helping the 
Board identify important trends in global trade. 
34. As at 31 October 2009, 108 States and territories 
had provided information on licit trade and  
101 Governments had furnished data on licit uses of 
and requirements for precursors for 2008 (see annex IV 
for details). As in previous years, the European 
Commission furnished data on behalf of all 27 States 
members of the European Union. Most States and 
territories submitting form D are also able to furnish 
information on the licit movement of at least some 
precursor chemicals. 
 
 H. Other action taken  
 
 
 1. Activities under Project Prism, the 
international initiative to address the diversion 
of chemicals used in the illicit manufacture of 
amphetamine-type stimulants 
 
35. Activities under Project Prism have continued to 
bring tangible results, with Governments exchanging 
information on legitimate trade and trafficking trends. 
As in the past, the Board has served as the international 
focal point for the exchange of such information. 
During the period, several special alerts on diversion-
related activities were circulated to all participating 
States. 
36. Given the results achieved with Operation Ice 
Block (which was in operation from 1 January to  
30 September 2008), the Project Prism Task Force 
decided to continue and expand those activities with 
the objective of continuing the exchange of 
intelligence on suspicious transactions and 
backtracking investigations. New initiatives focus on 
global trade in ephedrine and pseudoephedrine, with 
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special emphasis on pharmaceutical preparations, and 
on trade in P-2-P and phenylacetic acid.  
37. The Project Prism Task Force held two meetings 
to evaluate operational activities. The first meeting, 
held in Vienna on 17 March 2009, had the purpose of 
determining the nature of future cooperative action for 
2009 focusing on trade in ephedrine and 
pseudoephedrine. At the meeting, the Task Force took 
the unanimous decision that particular emphasis had to 
be placed on pharmaceutical preparations, as almost all 
suspicious shipments in the period between 1 October 
2008 and 10 March 2009 were related to 
pharmaceutical preparations. The second meeting in 
which a number of countries of Africa and West Asia 
were invited to take part as observers, was held in 
Vienna from 19 to 21 October 2009. At that meeting, 
the Task Force considered, in particular, the diversion 
and trafficking of precursors of amphetamine-type 
stimulants in those regions. The Task Force evaluated 
the operational period from July to October 2009 and 
decided to continue implementing the activities as 
planned. 
38. During the reporting period, 14 special 
communications on diversion-related activities were 
circulated to all participating States. Those special 
communications concerned shipments containing a 
total of 10 tons, as well as 31.83 million tablets, of 
ephedrine and pseudoephedrine that were suspended, 
stopped or seized. Of the 10 tons, 7.73 tons were of 
pharmaceutical preparations. The main country of 
origin was India, and the main destination was Mexico. 
 
 2. Activities under Project Cohesion, the 
international initiative to address the diversion 
of chemicals used in the illicit manufacture of 
cocaine and heroin  
 
39. The mutual cooperation of 84 States in Project 
Cohesion continued to yield positive results, as 
evidenced by a significant increase in seizures of acetic 
anhydride in 2008 and in identified diversion attempts 
in 2009. As focal point for the exchange of information 
under the Project, the Board continued to assist the 
Governments, for example, through the issuance of 
special alerts to all participating Governments.  
40. The Project Cohesion Task Force held a meeting 
in Wiesbaden, Germany, on 15 and 16 June 2009 to 
review the latest information on trafficking trends 
involving acetic anhydride. The Task Force examined 
the information available and noted an increasing 
number of suspicious orders for the substance placed in 
West Asia. To respond to the identified shifts in 
trafficking trends, the Task Force decided to continue 
with activities that would build on achievements of the 
Operation Dice, which was conducted in 2008. Those 
activities focused on the exchange of data on seizures, 
identified diversion attempts and suspicious shipments 
of acetic anhydride and other chemicals suspected of 
being used in the illicit manufacture of heroin.  
41. The activities under Project Cohesion relating to 
chemicals used in the illicit manufacture of cocaine lag 
behind those activities targeting precursors of heroin. 
There is insufficient understanding of the sources of 
chemicals used in the illicit manufacture of cocaine 
and the related diversion patterns and trafficking 
trends. The Board therefore recommends that the 
Task Force devise specific strategies and activities to 
counter the diversion of and trafficking in cocaine 
precursors without further delay. The Board 
requests all members of Project Cohesion, in 
particular countries of Latin America, to actively 
assist the Task Force in launching such operational 
activities. 
 
 
III. Extent of licit trade and latest 
trends in trafficking in precursors  
 
 
42. The following analysis provides an overview of 
the major trends identified for both the licit trade in 
precursor chemicals and illicit trafficking in these 
substances. That analysis was developed based on data 
provided by Governments on form D for 2008 and on 
data accumulated through the PEN Online system. The 
Board has been provided with additional information 
from a number of sources, including direct 
notifications from Governments and communications 
through the international cooperative initiatives Project 
Prism and Project Cohesion. Those data, received 
throughout 2009, were drawn on to identify 
developments and trends in illicit drug manufacturing 
for the period from 1 November 2008 to 31 October 
2009. The Board wishes to thank those Governments 
that assisted the Board by providing reports on specific 
cases of the diversion of precursors and other activities 
associated with illicit drug manufacture. 
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 A. Substances used in the illicit 
manufacture of amphetamine-type 
stimulants 
 
 
43. Between 1 November 2008 and 31 October 2009, 
Governments provided 2,810 pre-export notifications 
for consignments of substances used in the illicit 
manufacture of amphetamine-type stimulants. The 
Board initiated enquiries into the legitimacy of 278 of 
those shipments. 
 
 1. Ephedrine and pseudoephedrine  
 
  Licit trade 
 
44. Under Project Prism, during the period from  
1 November 2008 to 31 October 2009, Governments 
notified the Board of 2,683 international transactions 
involving 92 tons of ephedrine (in 475 shipments) and 
911 tons of pseudoephedrine (in 2,208 shipments). 
Those shipments originated in 34 exporting countries 
and territories and were to be sent to 125 importing 
countries and territories. 
 
  Trafficking  
 
45. As a result of enquiries raised by the Board under 
Project Prism in February 2008, Iranian authorities 
stopped two shipments of pseudoephedrine 
hydrochloride, of 8 tons and 3 tons, both destined for 
Ethiopia. The competent authorities of Ethiopia had 
objected to the shipments, as the purported importing 
company was fictitious and the import documentation 
was forged. Belgium reported the stopping of a 
50-kilogram (kg) shipment of ephedrine to the 
Democratic Republic of the Congo. Canada reported 
that three shipments of ephedrine, 200 kg each, had 
been stopped in 2008. That action was taken after the 
competent authorities of Iran (Islamic Republic of), the 
United Arab Emirates and Viet Nam had objected to 
the respective pre-export notifications issued by 
Canada in relation to those consignments.  
46. Canada also reported that a shipment containing 
approximately 51 kg of pseudoephedrine in the form of 
142,848 boxes of pharmaceutical preparations had 
been stopped prior to export to Panama, as the 
competent authorities of that country objected to the 
shipment. A later shipment comprising 156,528 boxes 
of an identical product, also to be exported to Panama, 
was similarly stopped. Thirteen shipments of 
substances listed in Table I were either stopped or 
detained by authorities of the United States in 2008. 
47. Twenty-three Governments informed the Board 
of seizures of ephedrine or pseudoephedrine through 
form D submissions for 2008. The total weight of 
seized raw ephedrine reported was 12,637.47 kg, with 
seizures of 6,700 kg in China and 3,293 kg in Mexico 
constituting the greater portion. Ephedrine seizures in 
Australia (1,103 kg), Myanmar (750 kg), the 
Philippines (204 kg), the Netherlands (135 kg), Canada 
(105 kg) and the United States (104 kg) and constituted 
virtually all of the remainder of the total quantity 
reported. The ephedrine seized in Mexico had 
originated in a number of countries including 
Argentina, Canada, the Hong Kong Special 
Administrative Region of China, India and the United 
Kingdom. 
48. In the same period, seventeen countries reported 
seizing pharmaceutical preparations containing 
ephedrine, for a total of 861.1 kg, with Belgium 
reporting 810 kg in two seizures and Australia and 
New Zealand reporting 27.8 kg and 23.3 kg of the 
products respectively.  
49. The total weight of raw pseudoephedrine that 
Governments reported on form D to have seized was 
5,130 kg, with Mexico recording the largest amount 
(2,873 kg), followed by China (1,100 kg), the United 
States (602 kg) and France (502 kg). 
50. Seventeen countries submitted data on seizures of 
pharmaceutical preparations containing pseudo-
ephedrine. Mexico recorded seven seizures, the largest 
consisting of 3,768 kg of tablets that had originated in 
China. Countries of Oceania reported interceptions of 
pseudoephedrine in tablet form, with Australian 
authorities seizing two concealed shipments of tablets 
from Thailand of 850 kg and 662 kg. New Zealand 
authorities seized a total of 622 kg of ephedrine in 
367 individual seizures. The seized pseudoephedrine 
was in the form of granules, originally manufactured to 
be marketed encased in capsules, and had been 
exported from 15 countries, with more than 300 of the 
seized consignments originating in China. 
51. Thai authorities reported the seizure in Phuket 
province of 192 kg of preparations containing 
pseudoephedrine that were about to be shipped to 
Australia. Thailand also reported the seizure of 
507,450 tablets containing pseudoephedrine at the  
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Thai border with Myanmar and the seizure of 
200,000 more tablets originating in Malaysia. The 
Government of Belize reported that more than 
10 million pseudoephedrine tablets had been destroyed 
in their country in 2008. The Netherlands seized 
5 million tablets in the same period. 
52. While the magnitude of the seized quantities of 
raw ephedrine and pseudoephedrine reported on 
form D is significant, the Board considers that those 
data provide only a partial view of the significance of 
this class of precursor in the illicit manufacture of 
methamphetamine. In particular, the limited 
information provided on the seizure of ephedrine and 
pseudoephedrine compounded in pharmaceutical 
preparations is insufficient to reveal the increasingly 
significant role of substances in that form in 
contributing to the global supply of amphetamine-type 
stimulants. During Operation Ice Block, the Project 
Prism initiative in operation between January and 
September 2008, the Board identified 49 suspicious 
transactions involving international trade in raw 
ephedrine and pseudoephedrine. The majority of the 
transactions involved raw material, with only 11 
relating to preparations. Since that time, data available 
to the Board, through the combined resources of PEN 
Online and data provided by countries participating in 
Project Prism, have shown a significant decline in 
identified attempts to divert raw ephedrine and 
pseudoephedrine from international trade channels. 
However, in 70 per cent of all instances of suspicious 
shipments or diversions identified in the reporting 
period, the substances were in the form of 
pharmaceutical preparations in tablet form. In many of 
those cases, the tableted products had been only 
roughly or partially packaged or shipped in bulk and 
were clearly never intended for sale through the 
legitimate pharmaceutical trade, thus demonstrating 
that illicit manufacturers are exploiting existing 
international regulations for those precursors in that 
form. The Board therefore recommends that all 
Governments control pharmaceutical preparations 
containing ephedrine and pseudoephedrine in the 
same way as they control the scheduled substances 
themselves. 
53. Coincident with this concerted movement to the 
diversion of precursors in the form of preparations, the 
diversion routes identified for raw ephedrine and 
pseudoephedrine since Operation Ice Block have also 
changed significantly. In Operation Ice Block, Africa 
was identified as the region in which the greatest 
number of diversions or attempted diversions took 
place, and activity in Africa under Project Prism 
prevented more than 60 per cent of the quantity at risk 
from falling into the hands of illicit manufacturers. 
54. In sharp contrast, information provided to the 
Board on suspicious or seized shipments in 2009 has 
identified only two attempted diversions to Africa: an 
attempted shipment of 1,250 kg of ephedrine to the 
Central African Republic and an attempted shipment of 
1,000 kg of pseudoephedrine to Kenya. In the same 
period, however, numerous instances of suspicious 
shipments and seizures in Central American countries 
were recorded. In nearly all cases, the consignments 
consisted of ephedrine and pseudoephedrine in the 
form of tableted pharmaceutical preparations and were 
believed to be ultimately destined for Mexico. Two 
major changes have been observed in how illicit 
manufacturers are now obtaining ephedrine and 
pseudoephedrine in this form. The supply routes 
through which the diverted preparations travel are now 
more complex than raw material shipment routes 
previously identified. More significantly however, 
shipments of ephedrine and pseudoephedrine in this 
form now originate not only in those countries where 
ephedrine and pseudoephedrine are manufactured but 
also in intermediate countries to which raw ephedrine 
and pseudoephedrine are imported and then formulated 
into pharmaceutical preparations. 
55. In many instances, the route by which tableted 
preparations were shipped to destinations in Central 
America passed through countries of the European 
Union. In October 2008, French authorities executed 
three seizures of pseudoephedrine preparations, the 
largest of which involved 11 million tablets transiting 
from the Syrian Arab Republic to Honduras. The other 
two shipments were destined for Guatemala, one 
originating in India and the other in Viet Nam. In 
November 2008, authorities in the United Kingdom 
detected a shipment of 1.65 million pseudoephedrine 
tablets in transit from India to Mexico. Further 
evidence of trafficking routes through European 
centres to destinations in the Americas was provided 
when Belgium reported on form D that authorities in 
that country had seized a shipment of 8.5 million 
ephedrine tablets originating in Taiwan Province of 
China and destined for Mexico. In May 2009, 
authorities of the Netherlands stopped a shipment of  
11 million pseudoephedrine tablets from Viet Nam 
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upon receipt of advice from Guatemalan authorities 
that the consignment destined for Guatemala was 
unauthorized. Further reports from Guatemala show 
that the country was the target of illicit traffickers in at 
least three instances, the largest being a shipment of 
more than 20 million tablets that was seized in the 
country in 2009. In June 2009, Mexican authorities 
seized an airfreight shipment containing 1.7 tons of 
pseudoephedrine in tablet form. The goods had been 
mislabelled and were believed to have originated in 
India and routed through Germany.  
56. Raw ephedrine and pseudoephedrine smuggled 
into Central America are being trans-shipped not only 
through European countries but also through North 
America. Traffickers are increasingly using South 
American countries as a trans-shipment point for raw 
ephedrine and pseudoephedrine ultimately destined for 
Mexico. In February 2009, United States authorities 
seized a shipment of 5 million pseudoephedrine tablets 
that originated in India and which was en route to 
Haiti. Bangladesh has also been identified as a source 
country for pharmaceutical preparations diverted into 
illicit drug manufacture. Between March and June 
2009, tablet shipments from Bangladesh were detected 
in Honduras (3 million tablets), and a second 
consignment of 2 million tablets in transit to Mexico 
was seized by Honduran authorities. Authorities in 
Mexico seized 198,000 tablets that had originated in 
Bangladesh, and authorities in the Dominican Republic 
seized a shipment declared as vitamin products. 
57. An examination of the seizures made by Mexican 
authorities in 2009 provides insight into the diverse 
origins of ephedrine and pseudoephedrine, both in raw 
form and in pharmaceutical preparations, that have 
been smuggled into the country with the intended 
purpose of conversion into methamphetamine. Chilean 
authorities reported a number of seizures of shipments 
bound for Mexico, the largest of which was 1,000 kg. 
A shipment of 8.02 million tablets, in transit from the 
Republic of Korea and which originated in India, was 
also seized in Mexico. Argentina was identified in 
2008 as a major source of diverted raw ephedrine and 
pseudoephedrine, and there were found to be multiple 
links in that country to Mexican drug cartels. In 
May 2009, Argentine authorities advised the Board that 
they believed that more than 17 tons of ephedrine had 
been diverted through their country to criminal 
networks in Mexico. To address the situation, the 
authorities introduced stricter controls on the 
importation and licit use of those products by their 
pharmaceutical industry. However, reports of seizures 
of the substance still persist. The most notable of those 
seizures took place in August 2009, when a series of 
significant confiscations of the precursor were made in 
close succession. Initially, 4 tons of ephedrine linked to 
earlier seizures were recovered from a customs 
warehouse as part of ongoing investigations into drug-
related organized crime in that country. Within weeks 
of that event, two separate seizures totalling some  
4.5 tons were made in one day in Buenos Aires.  
58. The Government of Mexico is currently engaged 
in a major effort to free the country from the grip of 
highly organized and powerful criminal networks. The 
power that those networks wield is directly linked to 
the vast wealth generated by the illicit manufacture and 
distribution of drugs, in particular methamphetamine, 
and the scale of the manufacturing infrastructure that 
such networks have constructed for that purpose is 
without parallel. The Board invites all Governments 
to support the Government of Mexico in its efforts 
against illicit methamphetamine manufacture, 
particularly through participation in activities 
under Project Prism. 
59. While numerous reports continue to come from 
Mexican authorities on seizures of illicit drug 
manufacturing laboratories and diverted chemical 
shipments, two particular seizures serve to demonstrate 
the unprecedented size and potential production 
capacity of many of these illicit facilities. In  
August 2009, authorities seized an illicit 
methamphetamine manufacturing complex in an 
isolated area in Durango, Mexico, comprising  
22 individual facilities dispersed and concealed in an 
area of 240 hectares. From that single site, authorities 
recovered a total of 32,800 litres of chemicals 
associated with the methamphetamine manufacturing 
process. Two months earlier, a laboratory was seized 
north of Culiacán, in the state of Sinaloa, Mexico. The 
facility was notable in that it provided indisputable 
evidence of the enormous scale of diversion of 
pharmaceutical preparations to illicit drug 
manufacture. Authorities recovered from the site a total 
of 49,640 litres of solution containing pseudoephedrine 
and dextromethorphan, a cough suppressant commonly 
used in many pharmaceutical preparations containing 
pseudoephedrine. The process being undertaken at the 
facility was the extraction of the precursor from that 
preparation in preparation for converting the isolated 
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pseudoephedrine into methamphetamine. A wide range 
of essential chemicals to be used in the conversion 
process were also found in substantial quantities at the 
site, including 3,250 kg of iodine, 1,850 litres of 
hypophosphorous acid and 3,250 kg of sodium 
hydroxide. The significance of those quantities can be 
grasped by comparing them with the quantities for 
2008 submitted by Mexico on form D: over the  
12-month period, 169.7 kg of iodine and 690.5 kg of 
sodium hydroxide were reported seized. 
60. The demand for precursors to meet the demands 
of illicit methamphetamine manufacture has had 
repercussions throughout the Americas as Governments 
seek to rid their countries of trans-shipments of these 
materials transiting their territory. Many Governments 
of Central and South America followed the path of 
Mexican legislators in introducing partial or 
comprehensive bans on raw ephedrine and 
pseudoephedrine. Countries adopting that strategy 
include Belize, Colombia, the Dominican Republic,  
El Salvador, Guatemala, Honduras and Nicaragua.  
61. Bangladesh, Egypt and the Syrian Arab Republic 
are among those countries whose imports of raw 
ephedrine and pseudoephedrine have recently 
increased substantially. In response to numerous 
enquiries, the Board has received repeated assurances 
that the materials imported are not for re-export. 
However, while they may not be re-exported as raw 
material, raw ephedrine and pseudoephedrine are likely 
to be formulated into pharmaceutical preparations and 
exported in that form. Evidence is widely available to 
demonstrate that raw ephedrine and pseudoephedrine 
in that form provide illicit drug manufacturers with 
their essential feedstocks for methamphetamine 
manufacture, but many of those countries in which 
pharmaceutical preparations are manufactured do not 
control such products. The Board urges all countries 
to utilize the PEN Online system to advise on 
exports of ephedrine and pseudoephedrine in all 
forms, whether raw or formulated into 
preparations. 
 
 2. Norephedrine and ephedra  
 
62. Illicit manufacturers are continuously working to 
broaden the scope of precursor substances that they can 
divert to the manufacture of amphetamine-type 
stimulants. In response to the strict controls on 
ephedrines recently introduced by many Governments, 
criminal networks appear to have renewed their interest 
in norephedrine, a precursor for amphetamine 
manufacture, as a potential alternative. Information 
provided to the Board shows an increase in the extent 
of diversion of norephedrine. In June 2008, India 
seized 900 kg of norephedrine in tablet form, which 
was to be shipped to Mexico. Another shipment of 
165 kg of the substance in raw form was seized in 
transit to Mexico by authorities in the Netherlands. In 
October 2008, Croatian authorities, working in 
conjunction with their Canadian counterparts, seized 
188 kg of norephedrine in their country, and a further 
223 kg was confiscated in Montreal, Canada, as a 
consequence of the joint operation. The substance had 
originated in India and been smuggled into Croatia 
concealed in machinery. In 2009, Australian authorities 
intercepted 22.8 kg of the substance, also concealed in 
machinery, which had originated in South Africa. 
63. Cambodian authorities reported an operation 
involving the seizure of 1,725 kg of extract of ephedra 
in March 2009, the ephedra having originated in 
northern China. Germany and Romania informed the 
Board on form D of seizures of ephedra of 535 kg and 
4.9 kg respectively. 
 
 3. 3,4-Methylenedioxyphenyl-2-propanone, 
phenylacetic acid and 1-phenyl-2-propanone 
 
  Licit trade  
 
64. Between 1 November 2008 and 31 October 2009, 
international trade reported through PEN Online 
revealed two countries exporting 3,4-MDP-2-P to two 
importing countries, with the total volume traded being 
less than five litres. Information supplied to the Board 
on form D for 2008 revealed two export transactions of 
the substances, totalling less than one litre. Five 
countries notified the Board of their estimated licit use 
requirements for the substance, and in all cases the 
quantities were very small. 
65. Two countries reported exports of P-2-P on 
form D, with one European country exporting 
53,584 litres to multiple countries. International trade 
in the substance between 1 November 2008 and 
31 October 2009 reported through PEN Online 
involved 13 shipments with a total volume of 
20,800 litres, and, of that volume, more than 95 per 
cent was destined for a single country in West Asia 
where the purported use as stated by the authorities 
was formulation into cleaning and disinfection 
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products. At the same time, authorities in many 
countries in West Asia are currently reporting 
extremely large seizures of tableted amphetamine-type 
stimulants, commonly containing amphetamine 
(referred to locally as “Captagon”). Because of the 
risk of diversion to illicit drug manufacture, the 
Board advises against the use of P-2-P, a prime 
precursor of amphetamine-type stimulants, in 
unregulated industrial and household products. 
Such diversion can be eliminated by substituting 
that precursor with one of many alternative 
chemicals available for the formulation of cleaning 
and disinfection products.  
66. In 2009, India stopped a shipment of 4,000 litres 
of P-2-P upon being informed by the authorities of the 
Syrian Arab Republic that the material destined for 
their country had not been ordered by the company 
named in the pre-export notification documentation. 
67. Five countries reported on form D exports of 
phenylacetic acid, totalling 77,437 kg. The exports 
were sent to 34 countries. In the same reporting period, 
eight Governments notified the Board through the PEN 
Online system of 86 shipments totalling 142.8 tons of 
phenylacetic acid. Fourteen countries provided the data 
on form D of imports of phenylacetic acid totalling 
2,693,793 kg. Mexico was the leading importer by far 
of phenylacetic acid in the period, importing 
2,242,821 kg of phenylacetic acid from a total of five 
countries.  
 
  Trafficking  
 
68. No country reported seizures of 3,4-MDP-2-P on 
form D. However, Canadian authorities reported 
through other channels that 2.8 tons of the substance 
were seized in 2008. Canadian authorities also reported 
that the illicit use of MDP-2-P in the manufacture of 
3,4-methylenedioxymethamphetamine (MDMA) using 
a process known as the “cold method” became 
prevalent in the province of British Columbia in 2008. 
The absence of any other seizure of MDP-2-P 
worldwide in the period ending October 2009 
continues the pattern observed in the past two years, in 
which the size and frequency of MDMA seizures have 
increased (for example, in 2007 Australian authorities 
seized 4.4 tons of tablets, the largest seizure of MDMA 
ever reported), but interception rates for its precursor 
continued to fall. 
69. It appears that the manufacture of 3,4-MDP-2-P 
used in clandestine drug manufacture is now entirely 
illicit and that its distribution is carried out by means 
of smuggling. In July 2009, authorities in Mexico 
announced the seizure of 4.2 tons of piperonal that 
originated in China. The United States notified the 
Board on form D of seizures of 1.38 tons of the 
substance in 2008. While the quantities reported by 
both Mexico and the United States are significant and 
are larger than the global total in previous years, the 
ratio of those seizures to the quantity of MDMA 
produced globally is low. In order to prevent the 
manufacture of 3,4-MDP-2-P, the Board urges all 
Governments to exercise adequate control measures 
over the substances from which that key precursor 
may be produced, in particular safrole, either as 
refined or in the form of safrole-rich oils, as well as 
piperonal. Such measures are especially necessary 
in regions where plants containing safrole-rich oils 
are grown and harvested. 
70. Eight countries submitted data on P-2-P seizures 
on form D. The Russian Federation notified the Board 
that 2,127 litres of P-2-P had been confiscated, and 
China notified the Board of the seizure of 2,857 litres. 
Lithuanian authorities reported the interception of a 
heavy vehicle carrying 563.5 litres of P-2-P concealed 
in a fuel tank. The vehicle was transiting the territory 
of Lithuania from Belarus and was believed to be 
destined for Western Europe. Poland and Estonia 
reported seizures of 39 litres and 22 litres of the 
substance respectively, with the remaining countries 
accounting for very small quantities. Chinese 
authorities reported that in March 2009 they had 
destroyed 8.7 tons of P-2-P, which was the 
accumulation from seizures in previous years. The 
Board notes that no seizure of any type was 
reported in or adjacent to the region of West Asia, 
where reports of interceptions of very large 
quantities of tableted amphetamine products are 
increasing. As amphetamine is almost invariably 
manufactured from P-2-P, the unrestricted 
availability in that region of industrial and domestic 
products containing P-2-P must be considered as a 
likely source of the diversion of the precursor. 
71. The data on phenylacetic acid seizures in 2008 
supplied by Governments on form D indicates 
quantities comparable to those of the preceding two 
years: a total of less than 160 kg was reported globally 
for 2008, and 153 kg of that amount was seized in one 
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country, Bulgaria. However, the information submitted 
to the Board in 2009 showed that phenylacetic acid 
now makes a very significant contribution, almost 
entirely in Mexico, to the illicit manufacture of 
amphetamine-type stimulants. While Mexico reported 
no seizures of the substance on form D for 2008, the 
Board is aware of reports that phenylacetic acid was 
playing an increasingly significant role in 
methamphetamine manufacture in the country. A 
catalyst for the change in manufacturing techniques 
was most certainly the introduction of the 
comprehensive ban on ephedrine and pseudoephedrine 
by the Government of Mexico in June 2008. Prior to 
that date, illicit manufacturers of methamphetamine 
had relied heavily on those two substances. In the 
period following the introduction of the prohibition of 
raw ephedrine and pseudoephedrine, the frequency of 
reports of phenylacetic acid detected at clandestine 
laboratories increased substantially. Confirming that 
trend was a communication from the Mexican 
authorities in August 2009, in which they reported that 
as of May 2009, nearly 18,000 kg of phenylacetic acid 
had been seized.  
72. In the examination of the circumstances that 
permitted the illicit manufacturers so rapidly to adopt 
synthetic methods using phenylacetic acid, two factors 
are of major significance. Mexican imports of 
phenylacetic acid are extremely large: more than  
2.2 million kg of authorized shipments entered the 
country in 2008. At the same time, there were no 
reported seizures of phenylacetic acid or identified 
diversions from international licit trade in the region. 
Thus, it is likely that domestic distribution channels 
were the source of a significant proportion of the 
phenylacetic acid diverted to illicit manufacture. The 
Board is aware of only a single instance of attempted 
diversion of the substance to Mexico since 2006. A 
proposed shipment of 8,000 kg of phenylacetic acid 
from China was stopped in August 2009 when Mexican 
authorities determined its documentation to be 
fraudulent. Notwithstanding those circumstances, the 
Government of Mexico has stated that it is of the belief 
that the major source of phenylacetic acid for illicit 
drug manufacture is the smuggling of the substance 
into the country from the United States by organized 
criminal groups and has advised the Board that they 
have initiated investigations to dismantle those 
networks. 
73. An indication of the extent to which the synthesis 
of P-2-P from phenylacetic acid has penetrated illicit 
drug manufacture is the observed frequency and scale 
of reported seizures of the chemicals used in the 
conversion of phenylacetic acid to P-2-P and in its 
subsequent conversion to methamphetamine. 
Information released by the Government of Mexico 
provides extensive evidence of the detection of 
essential chemicals, including sodium acetate, lead 
acetate and acetic anhydride, detected in large 
quantities at clandestine laboratory sites and covert 
storage facilities. Many of the chemicals used to 
process precursors are not subject to international 
controls.  
 
 4. Safrole and safrole-rich oils 
 
  Licit trade 
 
74. Four Governments reported on form D a total of 
159,641 litres of safrole — almost entirely in the form 
of safrole-rich oils — in international trade in 2008. In 
the same period, 265 litres of safrole in 19 export 
consignments were reported through the PEN Online 
system. The vast majority of the trade in safrole was in 
the form of sassafras oil, with 86,710 kg of the 
substance being traded in eight shipments.  
 
  Trafficking 
 
75. Canada was the only country to report stopped 
shipments of safrole, with all seven of the shipments 
reported being less than 1 litre in volume. Four 
countries reported seizures of safrole in 2008, totalling 
1,904 litres, of which 1,841 litres were confiscated in 
Estonia. In June 2009, the Government of Cambodia 
reported that 5.2 tons of sassafras oil had been 
discovered in the Phnom Sankos Wildlife Sanctuary, an 
area that is known for oil harvesting. Cambodian 
authorities have dismantled more than 50 illegal 
sassafras oil distilleries in recent years in order not 
only to stem the use of that substance in illicit drug 
manufacture but also to prevent the serious ecological 
damage that such illicit operations cause to the forest 
environment.  
76. Safrole extracted from natural sources is 
recognized to be the primary source of 3,4-MDP-2-P, 
either through the direct diversion and illicit 
conversion to that key MDMA precursor, or indirectly, 
through the diversion of piperonal, an extensively 
traded industrial chemical, which is made from safrole. 
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The quantities of safrole reported seized, like those of 
3,4-MDP-2-P and piperonal, are relatively low when 
seen in the context of world MDMA production.  
77. In July 2009, authorities in Guinea announced a 
series of chemical and equipment seizures at a number 
of locations in Conakry. Among the range of material 
seized, authorities found sassafras oil and several 
large-volume reaction vessels capable of operating at 
an elevated pressure. The findings provided substantial 
evidence that illicit manufacturers of amphetamine-
type stimulants are active in West Africa. It is an 
unfortunate reality that criminal organizations 
proliferate and prosper in regions confronted by a 
combination of limited law enforcement capacity and 
widespread poverty. The Board encourages 
Governments with the resources to do so to assist 
countries in Africa through the provision of 
appropriate training and capacity-building 
programmes. 
 
 5. Non-scheduled substances 
 
78. As controls strengthen on ephedrine and 
pseudoephedrine in North and Central America, 
criminal networks in both Canada and Mexico have 
turned to l phenylacetylcarbinol (l-PAC), an 
intermediate precursor used in the industrial 
manufacture of raw ephedrine and pseudoephedrine. 
l-PAC is converted into ephedrine and then further 
processed into methamphetamine. Authorities in 
Canada advised the Board that they had determined 
that the substance was being diverted in India and then 
shipped illicitly to Canada by circuitous means. Access 
to l-PAC enables illicit producers to continue to use 
familiar production techniques based on the reduction 
of raw ephedrine and pseudoephedrine and thus avoid 
the adoption of alternative synthetic methods in the 
wake of ephedrine controls. Given that l-PAC is not 
subject to international controls, the Board wishes to 
draw attention to the threat posed by that substance in 
illicit methamphetamine manufacture and 
recommends to Governments that have yet to do so 
to consider placing l-phenylacetylcarbinol under 
national controls. 
79. Australia reported on form D the detection of an 
unusual source of ephedrine: authorities in the country 
seized 128 kg of a powdered extract of the plant Sida 
cordifolia. The shipment had originated in India, and 
analysis revealed that the substance had an ephedrine 
content of 6-8 per cent. Sida cordifolia is known to 
contain a number of alkaloids including ephedrine. 
However, it has been encountered in an illicit context 
in Australia on only one previous occasion: in a very 
small clandestine laboratory producing methcathinone. 
The plant is used in a number of herbal medicaments, 
particularly in India, where it is cultivated 
commercially. It is widely found in a number of 
tropical and subtropical regions. The Board 
recommends that Governments monitor all natural 
product sources of ephedrine alkaloids in the same 
manner as is done with respect to Ephedra sp. 
80. In February 2009, Chinese authorities released 
details of the seizure of a large sophisticated illicit 
methamphetamine laboratory in Guangdong province 
carried out in August 2008. The operators of the 
complex were utilizing phenylacetonitrile and ethyl 
acetate to produce an intermediate precursor, 
α-phenylacetoacetonitrile, which was then converted to 
P-2-P. While this process has been documented in 
scientific literature, it has only rarely been encountered 
in the context of illicit drug manufacture. Sodium 
formate and tartaric acid were also recovered at the 
site. 
81. The form D data provided by China contained 
information on the seizure of 2,500 kg of thionyl 
chloride, a chemical frequently utilized by illicit 
manufacturers in the reduction of raw ephedrine and 
pseudoephedrine to methamphetamine.  
82. In August 2009, China announced that tighter 
controls were to be introduced on the manufacture of 
ephedrine, 3,4-MDP-2-P and P-2-P. Those controls 
would also apply to hydroxylimine hydrochloride  
(1-hydroxycycloamyl-(o-chlorophenyl)-N-methylimine 
hydrochloride), which is an immediate precursor in the 
industrial manufacture of ketamine.  
83. Both China and Mexico have reported seizures of 
tartaric acid associated with illicit methamphetamine 
manufacture, with Mexico recording multiple seizures 
of substantial quantities. The prevalence of tartaric acid 
in environments of illicit manufacturing is increasing 
in proportion with the growth in manufacturing 
processes utilizing P-2-P. Tartaric acid provides illicit 
manufacturers with a means of further refining the 
methamphetamine synthesized from P-2-P in order to 
increase the potency of the final product. 
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84. In October 2008, authorities in the Netherlands 
detected a quantity of P-2-P that had been chemically 
modified so as to no longer have the physical form of 
an oily, near-colourless liquid and thus circumvent 
controls. The substance was identified as 1-phenyl-2-
propanone bisulphite adduct (P-2-P or BMK bisulphite 
adduct). The substance has the physical appearance of 
a white, moist, crystalloid solid. The adduct can be 
easily reconverted to liberate the P-2-P with the 
application of readily available chemicals, a process 
requiring no chemical expertise. Application of that 
technique is not restricted to P-2-P, as 3,4-MDP-2-P 
shares key structural similarities with P-2-P and hence 
would also be susceptible to disguise through the 
formation of a bisulphite adduct. The chemical 
modification or “chemical masking” of key 
amphetamine-type stimulant precursors offers potential 
advantages to traffickers intent on shipping controlled 
chemicals internationally. In addition to the radical 
change in physical appearance of the substance, the 
modified precursor may not fall under the scope of 
national controls. 1-Phenyl-2-propanone bisulphite 
adduct does not fall within the definitions of the 
precursor substances controlled under the 
1988 Convention. The Board therefore urges 
Governments to exercise vigilance with regard to 
the possible “chemical masking” of scheduled 
precursors for illicit purposes. 
 
 
 B. Substances used in the illicit 
manufacture of cocaine 
 
 
  Potassium permanganate 
 
  Licit trade 
 
85. Between 1 November 2008 and 31 October 2009, 
the competent authorities of 28 exporting countries and 
territories provided 1,083 pre-export notifications to 
118 importing countries and territories, involving a 
total of 14,571 tons of potassium permanganate. The 
amount of the substance traded globally decreased 
considerably compared with the previous year. Only 
one shipment of 36 kg, originating in Spain and 
destined for the Syrian Arab Republic, was suspended. 
 
  Trafficking 
 
86. Fourteen countries reported on form D for 2008 
seizures of potassium permanganate totalling  
45,982 kg. Colombia seized 41,600 kg of the 
substance, constituting more than 90 per cent of the 
global seizures. Nearly 50 per cent of the seizures took 
place at sites where potassium permanganate was being 
illicitly manufactured. In comparison, in 2007, 
Colombia seized more than 140 tons of potassium 
permanganate. A seizure of 6,500 tons of manganese 
dioxide was reported by the Colombian authorities to 
have taken place in February 2009. The substance is 
used in the illicit manufacture of potassium 
permanganate.  
 
 
 C. Substances used in the illicit 
manufacture of heroin 
 
 
87. During the period from 1 November 2008 to  
31 October 2009, the authorities of 29 exporting 
countries and territories provided over 960 pre-export 
notifications for shipments of acetic anhydride. Those 
consignments were destined for 81 importing countries 
and territories, and the total amount of acetic anhydride 
involved was 135,000 tons. China and the United 
States were the largest exporters of the substance 
worldwide.  
 
  Trafficking 
 
88. In 2008, 20 countries reported seizures of acetic 
anhydride totalling 199,300 litres. Those seizures were 
142,000 litres greater than the total seizures in 2007 
(57,300 litres), and constituted the second largest 
seizure ever reported to the Board (208,200 litres were 
seized in 1998). The following countries, in descending 
order of seizure amounts, seized the substance in 
amounts exceeding 5,000 litres: Slovenia  
(86,100 litres), Hungary (63,600 litres), Pakistan 
(15,239 litres), Republic of Korea (14,800 litres), 
Turkey (10,553 litres) and China (5,186 litres). 
According to the information available, most of the 
acetic anhydride seized in 2008 had been diverted from 
domestic distribution channels. 
89. The African region emerged as a new target for 
traffickers seeking acetic anhydride. The number of 
identified diversion attempts involving countries in 
West Asia (in particular, Iraq) increased. In the 
European Union, the large-scale diversion of acetic 
anhydride from the intra-communitarian market 
occurred in several countries. In all major trading 
countries, in particular the States members of the 
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European Union and countries of East and South-East 
Asia, the threat of diversion of acetic anhydride from 
domestic distribution channels continues to be high. 
90. In 2008 and 2009, the traffickers increasingly 
used for their diversion attempts companies that were 
new in the precursor market. In Europe, orders for 
acetic anhydride were placed by small companies 
previously engaged in activities not related to trade in 
chemicals, for example, catering services. In Asia, 
some companies ordering acetic anhydride could not 
provide satisfactory explanations of their need for the 
substance. The consignments of acetic anhydride were 
often claimed to be used for purposes that were 
difficult to justify from an economic or practical point 
of view (e.g. manufacture of vinegar). The Board 
encourages Governments of all trading countries to 
strengthen their efforts to verify, to the extent 
possible, the legitimacy of the end-use of acetic 
anhydride in their countries. 
91. Some importing countries are providing 
insufficient feedback to the competent authorities of 
exporting countries regarding the verification of the 
legitimacy of suspicious consignments. The Board 
reminds Governments that, pursuant to article 12 of 
the 1988 Convention, parties to the Convention 
shall cooperate with one another to prevent the 
diversion of precursor substances. Should the 
verifications into the legitimacy of a pre-notified 
consignment of precursors require more time than 
that allocated by the exporting country in their pre-
export notification, the exporting country should be 
informed of that requirement accordingly.  
92. In Africa, the licit requirements for sizeable 
amounts of acetic anhydride are confined to a small 
number of importing countries including Egypt, 
Morocco and South Africa. In 2008, Egyptian 
authorities objected to a shipment of 15 tons of acetic 
anhydride from Italy. In 2009, India and the Islamic 
Republic of Iran, at the request of the authorities of 
Djibouti, stopped two shipments of acetic anhydride, 
consisting of 18.4 tons and 17.6 tons respectively, 
destined for Djibouti. The company in Djibouti seeking 
the import claimed to need the substance for the licit 
purpose of manufacturing pharmaceuticals. However, 
the authorities of Djibouti found that the import 
permits provided in support of the legitimacy of the 
shipments were forged. The Board urges all 
Governments in the region to be vigilant with 
regard to possible threats by trafficking 
organizations and to take measures to prevent 
diversions of acetic anhydride in their countries. 
93. Since 2000, seizures of acetic anhydride in the 
Americas totalling more than 100 litres were reported 
by, in descending order of seizure amounts, Colombia, 
Argentina, Venezuela (Bolivarian Republic of) and the 
United States. In Colombia, seizures for the 
period 2000-2008 totalled approximately 26,600 litres, 
far exceeding the total amount of the substance seized 
in the rest of the region. In the past, in addition to 
acetic anhydride, the Colombian authorities have also 
reported seizures of sizeable amounts of acetic acid for 
use in the clandestine heroin laboratories in the 
country. 
94. Seizures of more than 100 litres of acetic 
anhydride in 2008 were reported by the following 
countries in Europe, in descending order of seizure 
amounts: Slovenia, Hungary, Netherlands, Ukraine and 
Poland. The backtracking investigations into the origin 
of acetic anhydride seized in Slovenia and Turkey in 
2007 determined that the substance originated and was 
diverted in the European Union. In 2008 and 2009, 
attempts by traffickers to obtain the substance were 
identified in a number of countries of the European 
Union, including the Czech Republic, Hungary, 
Slovakia and Slovenia. Extensive joint law 
enforcement investigations of trafficking activities in 
the region resulted in seizures of 86,100 litres in 
Slovenia and 63,600 litres in Hungary. In May 2009, 
the Slovakian authorities seized a further 800 litres of 
acetic anhydride and prevented the diversion of further 
large amounts of the substance in the region.  
95. In 2008, seizures of acetic anhydride, purportedly 
originating in the European Union, were reported by 
Turkey and Ukraine. In 2008 and 2009, the Spanish 
authorities, in cooperation with the legitimate suppliers 
of the substance in their country, suspended suspicious 
shipments of acetic anhydride destined for Iran 
(Islamic Republic of), Iraq and the Syrian Arab 
Republic. Between late 2007 and the end of 2008, 
Germany prevented the delivery of suspicious 
shipments of acetic anhydride totalling 70 tons, 
destined in particular for countries in West Asia, 
including Afghanistan, Armenia, Iran (Islamic 
Republic of), Iraq, Pakistan, the United Arab Emirates 
and Uzbekistan. Suspicious inquiries for the supply of 
acetic anhydride to Afghanistan were also reported by 
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authorities in Switzerland. Control measures applied 
to internal trade in the European Union appear to 
be insufficient to prevent the diversion of the 
substance. The Board encourages the European 
Commission and States members of the European 
Union to introduce appropriate remedial measures. 
96. In late 2008 and early 2009, the number of orders 
for acetic anhydride placed by companies in Iraq 
increased significantly in a number of countries 
including Germany, India, Spain, the United Kingdom 
and the United States. Most of the proposed shipments 
were destined for companies that were apparently new 
in the precursor market, had no legitimate requirements 
for the substance or were not authorized to import the 
substance. From September 2008 to August 2009, the 
Government of Iraq, in cooperation with the authorities 
of exporting countries, prevented delivery to the 
country of a total of 95 tons of the substance. 
97. The Board notes efforts of the Government of 
Afghanistan to interdict chemicals used in the illicit 
manufacture of heroin. The Government, in addition to 
implementing measures to prevent imports of acetic 
anhydride into the country, supported regional anti-
trafficking activities such as Operation TARCET II. 
According to the United Nations Office on Drugs and 
Crime, authorities in Afghanistan seized over 
14,000 litres of acetic anhydride in 2008. However, the 
reply by the Government of Afghanistan to the annual 
questionnaire on substances frequently used in the 
illicit manufacture of narcotic drugs and psychotropic 
substances (form D) for 2008 did not contain any 
seizure data. The Board is therefore not in a position to 
confirm the amounts of precursor chemicals that have 
actually been seized in the country. The Board urges 
the Government of Afghanistan to improve the 
information provided to the Board in accordance 
with article 12 of the 1988 Convention with regard 
to seizures. 
98. The verification of the end-use of six tons of 
acetic anhydride imported to Armenia in 2008 revealed 
that the importing company did not use the substance 
for the manufacture of cellulose acetate as previously 
declared to the competent national authorities. In 
addition, in 2008, German authorities stopped a 
shipment to Armenia of 10 tons of acetic anhydride in 
what is believed to be an attempt to divert the 
substance. In the same year, the Dutch authorities, on 
the request of Syrian authorities, stopped a shipment of 
20 tons of the substance destined for the Syrian Arab 
Republic. In 2009, half a ton of acetic anhydride 
destined for the Syrian Arab Republic was stopped in 
Spain. 
99. In July 2009, the Government of Pakistan 
reported a seizure of five tons of acetic anhydride that 
was to be smuggled into Afghanistan. The Board noted 
that in 2009 seizures of sizeable amounts of acetic 
anhydride also occurred in Japan. However, the amount 
of the substance seized has not been confirmed by the 
Government.  
 
 
 IV. Conclusions 
 
 
100. The PEN Online system has become an essential 
tool for the monitoring of international trade in 
precursors. It is further being utilized with particular 
success in the international operations of the Board that 
address the diversion of some key chemicals used in 
the illicit manufacture of heroin, cocaine and 
amphetamine-type stimulants. Governments that have 
not yet done so are urged to register and utilize PEN 
Online.  
101. Importing Governments do not always take 
immediate action upon receiving pre-export 
notifications to examine whether or not the 
transactions in question are legitimate. Countries are 
not obliged to respond to pre-export notifications. It is 
in the interest of the importing Government to 
provide feedback to the exporting country if a 
transaction appears suspicious or requires 
additional time for checking. Should verification of 
the legitimacy of a pre-notified precursor 
consignment require more time than that allocated 
by the exporting country in their pre-export 
notification, the exporting country should be 
informed of this requirement accordingly. 
102. There are fewer diversions of chemicals from 
international trade thanks to the results achieved in 
monitoring precursors under the 1988 Convention. 
Most of the trafficking cases currently identified 
involve chemicals that are diverted from domestic 
distribution channels and then smuggled across 
borders. The Board draws the attention of all parties 
to the need to adequately monitor domestic 
manufacture and distribution in order to identify 
suspicious orders and prevent diversion, in 
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accordance with article 12, paragraph 8, of the 
1988 Convention. 
103. Multilateral mechanisms established under 
Project Prism and Project Cohesion have brought about 
identifiable results, as evidenced, for example, by a 
significant increase in seizures of acetic anhydride and 
identified diversion attempts in 2009. The Board will 
continue to assist Governments in its function as the 
focal point for the exchange of information under 
Project Prism and Project Cohesion, including through 
the issuance of special alerts to all participating 
Governments. The Board recommends that all 
Governments actively participate in these 
international initiatives.  
104. Data available to the Board have shown a 
significant decline in identified attempts to divert raw 
ephedrine and pseudoephedrine from international 
trade channels. Seventy per cent of all identified 
instances of suspicious shipments or diversions in the 
reporting period were in the form of pharmaceutical 
preparations. In a large number of those cases, the 
shipments were not destined for licit trade. The Board 
therefore reiterates its appeal to all Governments to 
control pharmaceutical preparations containing 
ephedrine and pseudoephedrine in the same way as 
they control the scheduled substances themselves. 
The Board urges all countries, at a minimum, to 
utilize the PEN Online system to advise of exports 
of ephedrine and pseudoephedrine in all forms, 
either raw or formulated into preparations. 
105. Recent cases provide substantial evidence that 
illicit manufacturers of amphetamine-type stimulants 
are active in West Africa. Criminal organizations 
proliferate and prosper in regions confronted by a 
combination of limited law enforcement capacity and 
poverty. The Board encourages Governments with 
the resources to do so to assist countries in Africa 
through the provision of appropriate training and 
capacity-building programmes. 
106. The 3,4-MDP-2-P used in clandestine drug 
production is now manufactured illicitly and 
distributed by means of smuggling. The ratio of the 
quantities reported seized to the quantity of MDMA 
manufactured globally is low. In order to prevent the 
illicit manufacture of 3,4-MDP-2-P, the Board 
strongly urges all Governments to exercise adequate 
control measures over the substances from which 
that key precursor may be produced, in particular 
safrole, either as refined or in the form of safrole-
rich oils, as well as piperonal. Such measures are 
especially necessary in regions where plants 
containing safrole-rich oils are harvested. 
107. There has been purported use of P-2-P for 
formulation into cleaning and disinfection products in 
some countries in West Asia. The Board notes that no 
seizures of P-2-P were recorded in or around the 
region of West Asia, where interceptions of very 
large quantities of tableted amphetamine products 
are increasing. As amphetamine is almost invariably 
manufactured from P-2-P, the unrestricted 
availability in that region of industrial and domestic 
products containing P-2-P is cause for concern.  
108. The Board acknowledges the efforts of the 
Government of Afghanistan and encourages that 
country to further strengthen measures to combat 
trafficking in precursor chemicals. The Board 
requests the Government of Afghanistan to comply 
with its treaty obligations regarding the furnishing 
of information on seizures of scheduled substances. 
109. In 2008, the Government of Afghanistan 
informed the Board that there was no legitimate use for 
acetic anhydride in Afghanistan and requested all 
producing and trading countries not to authorize any 
exports of acetic anhydride to that country. All 
Governments are encouraged, with a view to 
facilitating the appropriate investigations, to notify 
the Government of Afghanistan and the Board of 
any orders for the export of acetic anhydride to 
Afghanistan. 
110. Control measures applied to the internal trade of 
acetic anhydride within the European Union appear to 
be insufficient to prevent the diversion of that 
substance. The Board encourages the European 
Commission and States members of the European 
Union to take appropriate remedial measures.  
111. The activities of Project Cohesion targeting 
precursors of heroin are more developed than those 
relating to chemicals used in the illicit manufacture of 
cocaine. There is insufficient understanding of the 
sources of chemicals used in the illicit manufacture of 
cocaine and the related diversion patterns and 
trafficking trends. The Project Cohesion Task Force 
is therefore advised to devise specific strategies and 
activities to counter the diversion of and trafficking 
in cocaine precursors. The Board requests all 
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members of Project Cohesion, in particular those in 
the Americas, to actively assist the Task Force in 
launching such operational activities. 
112. Because of stronger monitoring of precursors, 
trafficking organizations are increasingly seeking out 
non-scheduled substances. All Governments are 
encouraged to make use of the Board’s updated 
international special surveillance list of non-
scheduled chemicals, which is available to 
competent national authorities. 
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Annex I 
 
 
  Parties and non-parties to the 1988 Convention, by region, 
as at 31 October 2009 
 
 
Note: The date on which the instrument of ratification or accession was deposited is indicated in 
parentheses. 
Region Party to the 1988 Convention Non-party to the 1988 Convention 
  
Africa Algeria  Djibouti Equatorial Guinea  
 (9 May 1995)  (22 February 2001)   
     Somalia  
 Angola   Egypt   
 (26 October 2005)  (15 March 1991)   
      
 Benin  Eritrea   
 (23 May 1997)  (30 January 2002)   
      
 Botswana  Ethiopia   
 (13 August 1996)  (11 October 1994)   
      
 Burkina Faso  Gabon   
 (2 June 1992)  (10 July 2006)   
      
 Burundi  Gambia   
 (18 February 1993)  (23 April 1996)   
     
 Cameroon  Ghana   
 (28 October 1991)  (10 April 1990)   
      
 Cape Verde  Guinea   
 (8 May 1995)  (27 December 1990)   
      
 Central African Republic   Guinea-Bissau   
 (15 October 2001)  (27 October 1995)   
      
 Chad  Kenya   
 (9 June 1995)  (19 October 1992)   
      
 Comoros  Lesotho   
 (1 March 2000)  (28 March 1995)   
      
 Congo  Liberia   
 (3 March 2004)  (16 September 2005)    
      
 Côte d’Ivoire  Libyan Arab Jamahiriya   
 (25 November 1991)  (22 July 1996)   
      
 Democratic Republic  Madagascar   
 of the Congo  (12 March 1991)   
 (28 October 2005)     
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Region Party to the 1988 Convention Non-party to the 1988 Convention 
  
 Malawi  Seychelles   
 (12 October 1995)  (27 February 1992)   
       
 Mali  Sierra Leone   
 (31 October 1995)  (6 June 1994)   
      
 Mauritania  South Africa   
 (1 July 1993)  (14 December 1998)   
        
 Mauritius  Sudan   
 (6 March 2001)  (19 November 1993)   
        
 Morocco  Swaziland   
 (28 October 1992)   (8 October 1995)   
       
 Mozambique  Togo   
 (8 June 1998)  (1 August 1990)   
       
 Namibia  Tunisia   
 (6 March 2009)  (20 September 1990)   
      
 Niger  Uganda   
 (10 November 1992)  (20 August 1990)   
       
 Nigeria  United Republic of   
 (1 November 1989)  Tanzania   
   (17 April 1996)    
 Rwanda     
 (13 May 2002)  Zambia   
   (28 May 1993)   
 Sao Tome and Principe      
 (20 June 1996)  Zimbabwe   
   (30 July 1993)   
 Senegal      
 (27 November 1989)     
      
Regional total      
53  51  2 
Americas Antigua and Barbuda  Belize   
  (5 April 1993)  (24 July 1996)   
       
  Argentina   Bolivia (Plurinational   
  (10 June 1993)  State of)a   
    (20 August 1990)   
  Bahamas     
  (30 January 1989)  Brazil   
    (17 July 1991)   
  Barbados      
  (15 October 1992)  Canada    
   (5 July 1990)   
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Region Party to the 1988 Convention Non-party to the 1988 Convention 
  
 Chile  Mexico   
 (13 March 1990)  (11 April 1990)   
      
 Colombia  Nicaragua   
 (10 June 1994)  (4 May 1990)   
       
 Costa Rica  Panama   
  (8 February 1991)  (13 January 1994)   
       
 Cuba  Paraguay   
  (12 June 1996)  (23 August 1990)   
       
  Dominica  Peru    
  (30 June 1993)  (16 January 1992)   
       
  Dominican Republic  Saint Kitts and Nevis    
  (21 September 1993)  (19 April 1995)   
       
 Ecuador  Saint Lucia    
  (23 March 1990)  (21 August 1995)   
       
  El Salvador  Saint Vincent and the   
  (21 May 1993)  Grenadines   
     (17 May 1994)   
  Grenada       
 (10 December 1990)  Suriname    
   (28 October 1992)    
  Guatemala      
  (28 February 1991)  Trinidad and Tobago     
     (17 February 1995)   
  Guyana     
  (19 March 1993)  United States of    
    America   
  Haiti  (20 February 1990)   
  (18 September 1995)     
     Uruguay   
  Honduras  (10 March 1995)   
  (11 December 1991)     
     Venezuela (Bolivarian   
  Jamaica  Republic of)   
  (29 December 1995)  (16 July 1991)    
      
Regional total       
35  35  0  
Asia Afghanistan  Azerbaijan Timor-Leste 
  (14 February 1992)  (22 September 1993)  
       
  Armenia   Bahrain   
  (13 September 1993)  (7 February 1990)   
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Region Party to the 1988 Convention Non-party to the 1988 Convention 
  
 Bangladesh  Lao People’s   
 (11 October 1990)  Democratic Republic   
   (1 October 2004)   
 Bhutan     
 (27 August 1990)  Lebanon   
   (11 March 1996)   
 Brunei Darussalam      
 (12 November 1993)  Malaysia   
   (11 May 1993)   
 Cambodia     
  (2 April 2005)  Maldives   
   (7 September 2000)   
  China     
  (25 October 1989)  Mongolia   
    (25 June 2003)   
  Democratic People’s      
  Republic of Korea  Myanmar   
  (19 March 2007)  (11 June 1991)   
       
  Georgia  Nepal   
 (8 January 1998)  (24 July 1991)   
        
  India  Oman   
  (27 March 1990)  (15 March 1991)   
        
  Indonesia  Pakistan   
  (23 February 1999)  (25 October 1991)   
        
  Iran (Islamic Republic of)  Philippines   
  (7 December 1992)  (7 June 1996)   
       
  Iraq  Qatar   
  (22 July 1998)  (4 May 1990)   
        
  Israel  Republic of Korea   
  (20 March 2002)  (28 December 1998)   
        
  Japan  Saudi Arabia   
  (12 June 1992)  (9 January 1992)   
        
  Jordan  Singapore   
  (16 April 1990)  (23 October 1997)   
        
  Kazakhstan  Sri Lanka   
  (29 April 1997)  (6 June 1991)   
       
  Kuwait  Syrian Arab Republic   
  (3 November 2000)  (3 September 1991)   
       
  Kyrgyzstan  Tajikistan   
  (7 October 1994)  (6 May 1996)   
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Region Party to the 1988 Convention Non-party to the 1988 Convention 
  
 Thailand  Uzbekistan   
 (3 May 2002)  (24 August 1995)   
       
 Turkey  Viet Nam   
 (2 April 1996)  (4 November 1997)   
      
 Turkmenistan  Yemen   
 (21 February 1996)  (25 March 1996)   
      
 United Arab Emirates     
 (12 April 1990)     
      
Regional total      
46  45  1  
Europe Albania Finlandb Holy See 
 (27 July 2001)  (15 February 1994)   
       
 Andorra  Franceb    
  (23 July 1999)  (31 December 1990)   
      
 Austriab  Germanyb   
 (11 July 1997)  (30 November 1993)   
        
  Belarus   Greeceb   
  (15 October 1990)  (28 January 1992)   
        
  Belgiumb  Hungaryb   
  (25 October 1995)  (15 November 1996)   
        
  Bosnia and Herzegovina  Iceland    
  (1 September 1993)  (2 September 1997)   
       
  Bulgariab  Irelandb   
  (24 September 1992)  (3 September 1996)   
         
  Croatia  Italyb   
  (26 July 1993)  (31 December 1990)   
         
  Cyprusb  Latviab   
  (25 May 1990)  (25 February 1994)   
       
  Czech Republicb  Liechtenstein    
  (30 December 1993)  (9 March 2007)   
        
  Denmarkb  Lithuaniab    
  (19 December 1991)  (8 June 1998)   
       
 Estoniab  Luxembourgb   
 (12 July 2000)  (29 April 1992)   
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Region Party to the 1988 Convention Non-party to the 1988 Convention 
  
 Maltab  Serbia   
 (28 February 1996)  (3 January 1991)   
      
 Monaco  Slovakiab   
 (23 April 1991)  (28 May 1993)   
      
 Montenegro  Sloveniab   
 (3 June 2006)  (6 July 1992)   
      
 Netherlandsb  Spainb   
 (8 September 1993)  (13 August 1990)   
      
  Norway  Swedenb   
  (14 November 1994)  (22 July 1991)   
        
  Polandb  Switzerland   
  (26 May 1994)  (14 September 2005)   
        
 Portugalb  The former Yugoslav    
  (3 December 1991)  Republic of Macedonia   
    (13 October 1993)   
  Republic of Moldova      
  (15 February 1995)  Ukraine   
    (28 August 1991)   
  Romaniab      
  (21 January 1993)  United Kingdom   
     of Great Britain   
  Russian Federation  and Northern Irelandb   
  (17 December 1990)  (28 June 1991)   
       
  San Marino  European Communityc   
  (10 October 2000)  (31 December 1990)   
      
Regional total      
46  45  1  
Oceania Australia  New Zealand Kiribati 
  (10 November 1992)  (16 December 1998)    
     Marshall Islands  
  Cook Islands  Samoa   
  (22 February 2005)  (19 August 2005) Nauru  
        
  Fiji  Tonga Palau  
  (25 March 1993)  (29 April 1996)    
     Papua New Guinea  
  Micronesia  Vanuatu   
  (Federated States of)  (26 January 2006) Solomon Islands  
  (6 July 2004)      
    
Tuvalu 
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Region Party to the 1988 Convention Non-party to the 1988 Convention 
  
Regional total          
15   8  7  
World total      
195  184  11  
a Since 31 March 2009, “Plurinational State of Bolivia” has replaced “Bolivia” as the short form used in the  
United Nations. 
b State member of the European Union. 
c Extent of competence: article 12. 
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Annex II 
 
 
  Submission of information by Governments pursuant to 
article 12 of the 1988 Convention (form D) for the 
years 2004-2008 
 
 
Notes: The names of non-metropolitan territories and special administrative regions are in 
italics. 
  A blank signifies that form D was not received. 
 X signifies that a completed form D (or equivalent report) was submitted, including nil 
returns. 
 Entries for parties to the 1988 Convention (and for the years that they have been 
parties) are shaded. 
Country or territory  2004 2005 2006 2007 2008 
Afghanistan     
 
 X 
Albania   X  X X X 
Algeria   X X X X X 
Andorra   X X X X X 
Angola     X 
Anguillaa        
Antigua and Barbuda  X     
Argentina   X X X X  
Armenia   X X X X X 
Arubaa        
Ascension Island X X X X X 
Australia   X X X X X 
Austriab   X X X X X 
Azerbaijan    X  X X 
Bahamas        
Bahrain    X    
Bangladesh   X X X X X 
Barbados   X     
Belarus   X X X X X 
Belgiumb    X X X X X 
Belize       X 
Benin   X X X X X 
Bermudaa   X X  X   
Bhutan      X  
Bolivia   X X X  X 
Bosnia and Herzegovina   X X X X 
Botswana   X X X  X 
Brazil   X X X X X 
British Virgin Islandsa       
Brunei Darussalam  X X X X X 
Bulgariab   X X X X X 
Burkina Faso   X X X   
Burundi        
Cambodia X X X X  
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Country or territory  2004 2005 2006 2007 2008 
Cameroon   X X  X X 
Canada   X X X X X 
Cape Verde        
Cayman Islandsa       
Central African Republic       
Chad   X X    
Chile   X X X X X 
China   X X X X X 
 Hong Kong SAR X X X X X 
 Macao SAR   X X X X X 
Christmas Islanda  Xc Xc Xc Xc Xc 
Cocos (Keeling) Islandsa  Xc Xc Xc Xc Xc 
Colombia   X X X X X 
Comoros        
Congo X X X  X 
Cook Islands X X X X X 
Costa Rica   X X X X X 
Côte d’Ivoire      X X 
Croatia    X X X X 
Cuba      X X X 
Cyprusb   X X X X X 
Czech Republicb  X X X X X 
Democratic People’s Republic of Korea  X X X X 
Democratic Republic of the Congo   X X X 
Denmarkb   X X X X X 
Djibouti        
Dominica      X  
Dominican Republic  X  X X X 
Ecuador   X X X X X 
Egypt   X X X X X 
El Salvador   X X X X X 
Equatorial Guinea      
Eritrea   X X    
Estoniab   X X X X X 
Ethiopia   X X X X X 
Falkland Islands (Malvinas) X X X X X  
Fiji        
Finlandb   X X X X X  
Franceb   X X X X X 
French Polynesiaa  Xd Xd Xd Xd  
Gabon      
Gambia        
Georgia   X X X X X 
Germanyb   X X X X X  
Ghana        
Gibraltar      
Greeceb   X X X X X  
Grenada        
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Country or territory  2004 2005 2006 2007 2008 
Guatemala   X  X  X 
Guinea        
Guinea-Bissau       X X 
Guyana    X X X X 
Haiti   X X X X X 
Honduras     X X  
Hungaryb    X X X X X 
Iceland    X X X X 
India   X X X X  
Indonesia   X X X X X  
Iran (Islamic Republic of)    X X X 
Iraq      X X 
Irelandb    X X X X X 
Israel   X  X   
Italyb   X X X X X 
Jamaica   X X X X X 
Japan   X X X X X 
Jordan   X X X X X 
Kazakhstan   X X X X  
Kenya   X    X  
Kiribati      
Kuwait        
Kyrgyzstan   X X X X X 
Lao People’s Democratic Republic X X X X  
Latviab   X X X X X 
Lebanon    X X X X X 
Lesotho        
Liberia      
Libyan Arab Jamahiriya    X   
Lithuaniab   X X X X X 
Luxembourgb   X X X  X 
Madagascar    X X  X 
Malawi    X X X X 
Malaysia    X X  X 
Maldives   X X X  X  
Mali         
Maltab    X X X X X 
Marshall Islands      
Mauritania   X X X  X 
Mauritius   X X X X  
Mexico   X X X X X  
Micronesia (Federated States of) X X X   
Monaco    X X X  
Mongolia      
Montenegroe    X X 
Montserrata   X X X X  
Morocco   X X X X X  
Mozambique    X X X X 
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Country or territory  2004 2005 2006 2007 2008 
Myanmar   X X X X X 
Namibia   X   
Nauru X X X X  
Nepal     X   
Netherlandsb   X X X X X  
Netherlands Antillesa  X X X X X 
New Caledoniaa  X X X   
New Zealand   X X X X X 
Nicaragua   X X X X X 
Niger      X  
Nigeria   X X    
Norfolk Islanda  Xc Xc Xc Xc Xc 
Norway   X X X X X 
Oman     X  X 
Pakistan   X X X X X 
Palau      
Panama   X X X X X  
Papua New Guinea   X X  
Paraguay   X  X  X 
Peru   X X X X X 
Philippines   X X X X X 
Polandb   X X X X X  
Portugalb   X X X X X 
Qatar        
Republic of Korea  X X X X X  
Republic of Moldovaf  X X X X X 
Romaniab   X X X X X 
Russian Federation  X X X X X 
Rwanda   X X X X X 
Saint Helena X X  X X  
Saint Kitts and Nevis       
Saint Lucia    X  X X 
Saint Vincent and the Grenadines  X X   
Samoa  X X   
San Marino        
Sao Tome and Principe   X X X X X 
Saudi Arabia   X X X X X 
Senegal   X X X   
Serbia     X X X 
Seychelles   X    X 
Sierra Leone        
Singapore   X X X X X 
Slovakiab   X X X X X  
Sloveniab   X X X X X  
Solomon Islands X     
Somalia      
South Africa   X X X X  
Spainb   X X X X X  
   
 
31
 E/INCB/2009/4
Country or territory  2004 2005 2006 2007 2008 
Sri Lanka   X X X X  
Sudan     X   
Suriname   X     
Swaziland    X     
Swedenb   X X X X X  
Switzerland X X X X X  
Syrian Arab Republic  X X X X X 
Tajikistan   X X X X X 
Thailand   X X X X X  
The former Yugoslav Republic of Macedonia      
Timor-Leste        
Togo     X   
Tonga     X X  
Trinidad and Tobago  X X X X X 
Tristan da Cunha X X X X X  
Tunisia   X X X X X 
Turkey    X X X X X 
Turkmenistan    X  X X X 
Turks and Caicos Islandsa    X   
Tuvalu      
Uganda   X  X X X 
Ukraine   X X X X X  
United Arab Emirates  X X X X X 
United Kingdom of Great Britain and Northern Irelandb X X X X X  
United Republic of Tanzania  X  X   
United States of America  X X X X X 
Uruguay    X X X  
Uzbekistan   X X X X X 
Vanuatu   X X  
Venezuela (Bolivarian Republic of)    X X X X 
Viet Nam   X X X X X 
Wallis and Futuna Islandsa       
Yemen    X X X X X  
Zambia   X X X X  
Zimbabwe        
Total number of Governments that submitted form Dh 135 137 152 137 132 
Total number of Governments requested to provide 
information 212 212 213 213 213 
 
a Territorial application of the 1988 Convention has been confirmed by the authorities concerned. 
b State member of the European Union. 
c Information was provided by Australia. 
d Information was provided by France. 
e By its resolution 60/264 of 28 June 2006, the General Assembly decided to admit Montenegro to membership in the 
United Nations. 
f Since 9 September 2008, “Republic of Moldova” has replaced “Moldova” as the short name used in the United Nations. 
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g Following the Declaration of Independence by the National Assembly of Montenegro on 3 June 2006, the President of the 
Republic of Serbia notified the Secretary-General that the membership of the state union of Serbia and Montenegro in the United 
Nations, including all organs and organizations of the United Nations system, was continued by the Republic of Serbia, which 
remained responsible in full for all the rights and obligations of the state union Serbia and Montenegro under the Charter of the 
United Nations. Since 3 June 2006, the Republic of Serbia has acted in the United Nations under the designation “Serbia”.  
h In addition, the Commission of the European Communities has submitted form D for the years 1993-2008. 
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Annex III 
 
 
  Seizures of substances in Tables I and II of the 
1988 Convention as reported to the International 
Narcotics Control Board 
 
 
1. Tables A.1 and A.2 below show information on seizures of the substances 
included in Tables I and II of the United Nations Convention against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances of 1988, furnished to the International 
Narcotics Control Board by Governments in accordance with article 12, 
paragraph 12, of the Convention. 
2. The tables include data on domestic seizures and on seizures effected at points 
of entry or exit. They do not include reported seizures of substances where it is 
known that the substances were not intended for the illicit manufacture of drugs  
(for example, seizures effected on administrative grounds or seizures of 
ephedrine/pseudoephedrine preparations to be used as stimulants). Stopped 
shipments are also not included. The information may include data submitted by 
Governments through means other than form D. 
 
  Units of measure and conversion factors 
 
3. Units of measure are indicated for every substance. As fractions of full units 
are not listed in the tables, figures are rounded as necessary. 
4. For a variety of reasons, individual quantities of some substances seized are 
reported to the Board using different units; for instance, one country may report 
seizures of acetic anhydride in litres, another in kilograms. 
5. To enable a proper comparison of collected information, it is important that all 
data are collated in a standard format. To simplify the necessary standardization 
process, figures are given in grams or kilograms where the substance is a solid and 
in litres where the substance (or its most common form) is a liquid. 
6. Seizures of solids reported to the Board in litres have not been converted into 
kilograms and are not included in the tables, as the actual quantity of substance in 
solution is not known. 
7. For seizures of liquids, quantities reported in kilograms have been converted 
into litres using the following factors: 
 
Substance 
Conversion factor  
(kilograms to litres)a 
  
Acetic anhydride 0.926 
Acetone 1.269 
Ethyl ether 1.408 
Hydrochloric acid (39.1% solution) 0.833 
Isosafrole 0.892 
3,4-Methylenedioxyphenyl-2-propanone 0.833 
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Substance 
Conversion factor  
(kilograms to litres)a 
  
Methyl ethyl ketone 1.242 
1-Phenyl-2-propanone 0.985 
Safrole 0.912 
Sulphuric acid (concentrated solution) 0.543 
Toluene 1.155 
 
 a Derived from density (The Merck Index (Rahway, New Jersey, Merck, 1989)).  
 
 
8. As an example, to convert 1,000 kilograms of methyl ethyl ketone into litres, 
multiply by 1.242, i.e. 1,000 × 1.242 = 1,242 litres. 
9. For the conversion of gallons to litres it has been assumed that in Colombia 
the United States gallon is used, with 3.785 litres to the gallon, and in Myanmar the 
imperial gallon, with 4.546 litres to the gallon. 
10. If reported quantities have been converted, the converted figures are listed in 
the tables in italics. 
11. The names of territories appear in italics in the tables. 
12. A dash (–) signifies nil (the report did not include data on seizures of the 
particular substance in the reporting year). 
13. A degree symbol (°) signifies less than the smallest unit of measurement 
shown for that substance (for example, less than 1 kilogram). 
14. Discrepancies may occur with the regional total seizure figures and the world 
total figures because of rounding to whole numbers of the actual quantities seized. 
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Table A.1 
Seizures of substances in Table I of the 1988 Convention as reported to the International Narcotics Control Board, 
2004-2008 
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Africa    
Côte d’Ivoire    
2007 – – º – – – – – – – – – – – 
               
South Africa    
2004 18 – 94 – – – – – – – – – – – 
2005 25 – 13 – – – – – – – – º 1 – 
2006 13 – 10 – – – – – – – – – – – 
2007 7 – – – – – – – – – – – – – 
               
Zambia    
2004 – – º – – – – – – – – – – – 
2005 – – º – – – – – – – – – – – 
    
Regional total    
2004 18 0 94 0 0 0 0 0 0 0 0 0 0 0 
2005 25 0 13 0 0 0 0 0 0 0 0 0 1 0 
2006 13 0 10 0 0 0 0 0 0 0 0 0 0 0 
2007 7 0 0 0 0 0 0 0 0 0 0 0 0 0 
2008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
    
Americas    
               
Central America    
Costa Rica    
2006 – – – – – – – – – – – – 3 – 
2007 – – – – – – – – – – – – 3 – 
2008 – – – – – – – – – – – – 3 – 
               
 E/IN
C
B/2009/4 
36 
Country or 
territory, 
by region       Year A c
e
t
i
c
 
a
n
h
y
d
r
i
d
e
 
(
l
i
t
r
e
s
)
 
N
-
A
c
e
t
y
l
a
n
t
h
r
a
n
i
l
i
c
 
a
c
i
d
 
(
k
i
l
o
g
r
a
m
s
)
 
E
p
h
e
d
r
i
n
e
 
(
k
i
l
o
g
r
a
m
s
)
 
E
r
g
o
m
e
t
r
i
n
e
 
(
g
r
a
m
s
)
 
E
r
g
o
t
a
m
i
n
e
 
(
g
r
a
m
s
)
 
I
s
o
s
a
f
r
o
l
e
 
(
l
i
t
r
e
s
)
 
L
y
s
e
r
g
i
c
 
a
c
i
d
 
(
g
r
a
m
s
)
 
3
,
4
-
M
D
P
-
2
-
P
a
 
(
l
i
t
r
e
s
)
 
1
-
P
h
e
n
y
l
-
2
-
p
r
o
p
a
n
o
n
e
 
(
l
i
t
r
e
s
)
 
N
o
r
e
p
h
e
d
r
i
n
e
 
(
k
i
l
o
g
r
a
m
s
)
 
P
i
p
e
r
o
n
a
l
 
(
g
r
a
m
s
)
 
P
o
t
a
s
s
i
u
m
 
p
e
r
m
a
n
g
a
n
a
t
e
 
(
k
i
l
o
g
r
a
m
s
)
 
P
s
e
u
d
o
e
p
h
e
d
r
i
n
e
 
(
k
i
l
o
g
r
a
m
s
)
 
S
a
f
r
o
l
e
 
(
l
i
t
r
e
s
)
 
Dominican Republic    
2008 – – – – – – – – – – – – 14 – 
               
El Salvador    
2008 – – 3 – – – – – – – – – – – 
               
Guatemala    
2006 – – 1 – – – – – – – – – – – 
               
Panama    
2006 – – – – 5 000 – – – – – – – – – 
2007 – – 10 000 – – – – – – – – – – – 
    
Subregional total    
2004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2006 0 0 1 0 5 000 0 0 0 0 0 0 0 3 0 
2007 0 0 10 000 0 0 0 0 0 0 0 0 0 3 0 
2008 0 0 3 0 0 0 0 0 0 0 0 0 17 0 
    
North America    
Canada    
2004 – – 1 251 – – – – 1 481 – – 200 000 – – 45 
2005 º – 53 – 105 – 109 3 942 – º – – º – 
2006 – – 1 730 – – – º 7 378 1 – – – º – 
2007 – – 246 – – – – 370 59 – – – – – 
2008 – – 105 – – – – – – – – – – – 
               
Mexico    
2005 10 – 7 – – – – – – – 4 000 000 40 000 526 – 
2007 10 – 3 696 – – – – – – – 2 000 010 10 12 216 – 
2008 4 – 3 293 – – – – – – – – – 2 874 – 
               
United States   
2004 6 122 818 – – – – – 2 1 – 59 174 423 18 
2005 83 5 1 370 – – 1 – – 1 – 1 000 93 82 6 
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2006 77 1 229 – 9 – – – 2 1 – 143 289 5 
2007 4 – 1 181 – 10 000 – – º 2 1 132 – 2 4 562 6 
2008 39 5 104 – – – – – 3 – 1 383 000 6 602 3 
    
Subregional total    
2004 6 122 2 069 0 0 0 0 1 481 2 1 200 000 59 174 423 63 
2005 93 5 1 430 0 105 1 109 3 942 1 0 4 001 000 40 093 608 6 
2006 77 1 1 959 0 9 0 0 7 378 3 1 0 143 289 5 
2007 14 0 5 123 0 10 000 0 0 370 61 1 132 2 000 010 12 16 778 6 
2008 43 5 3 502 0 0 0 0 0 3 0 1 383 000 6 3 476 3 
    
South America    
Argentina    
2006 – – 1 – – – – – – – – 2 – – 
2007 – – 382 – – – – – – – – º – – 
               
Bolivia    
2004 – – – – – – – – – – – 106 – – 
2005 – – – – – – – – – – – 232 – – 
               
Brazil    
2005 – – – – – – – – – – – 36 – – 
2006 – – – – – – – – – – – 82 – – 
2007 3 – – – – – – – – – – 700 – – 
               
Chile    
2008 – – – – – – – – – – – 12 – – 
               
Colombia    
2004 780 – – – – – – – – – – 170 320 – – 
2005 140 – – – – – – – – – – 140 675 – – 
2006 8 798 – – – – – – – – – – 98 904 – – 
2007 4 672 – – – – – – – – – – 144 401 – – 
2008 30 – – – – – – – – – – 41 630 – – 
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Ecuador    
2004 29 – – – – – – – – – – º – – 
2006 – – – – – – – – – – – 300 – – 
2008 – – – – – – – – – – – 775 – – 
               
Paraguay    
2006 – – – – – – – – – – – 50 – – 
               
Peru    
2004 – – – – – – – – – – – 100 – – 
2005 – – – – – – – – – – – 67 – – 
2006 – – – – – – – – – – – 1 337 – – 
2007 – – – – – – – – – – – 1 502 – – 
2008 – – – – – – – – – – – 516 – – 
    
Subregional total    
2004 809 0 0 0 0 0 0 0 0 0 0 170 526 0 0 
2005 140 0 0 0 0 0 0 0 0 0 0 141 010 0 0 
2006 8 798 0 1 0 0 0 0 0 0 0 0 100 674 0 0 
2007 4 675 0 382 0 0 0 0 0 0 0 0 146 603 0 0 
2008 30 0 0 0 0 0 0 0 0 0 0 42 933 0 0 
    
Asia    
               
East and South-East Asia   
Chinab    
2004 12 323 10 000 5 927 – – – – 5 331 23 345 – 13 100 000 – – 5 519 
2005 11 891 – 36 184 – 276 000 – – 2 1 153 – 168 000 – – – 
2006 2 126 – 5 319 – – – – – – – – – – – 
2007 5 297 – 5 860 – – – – – – – – – – – 
2008 5 186 – 6 700 – – – – – 2 857 – – – 1 100 – 
               
 Hong Kong SAR    
2004 – – 1 – – – – 1 42 – – 2 1 – 
2005 – – 1 – – – – 3 356 º – – – º – 
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 Macao SAR    
2007 – – – – – – – – – – – 5 – – 
               
Indonesia    
2005 – – 270 – – – – 77 77 – – – – – 
2008 – – 111 – – – – – – – – 2 – – 
               
Myanmar    
2004 26 – 183 – – – – – – – – – – – 
2005 1 638 – 325 – – – – – – – – – – – 
2006 1 401 – 1 288 – – – – – – – – – – – 
2007 959 – 530 – – – – – – – – – – – 
2008 1 142 – 751 – – – – – – – – – – – 
               
Philippines    
2004 – – 4 088 – – – – – – – – – 1 740 – 
2005 – – 1 645 – – – – – – – – – – – 
2006 – – 71 – – – – – – – – – – – 
2007 – – 35 – – – – – – – – – – – 
2008 – – 204 – – – – – – – – – – – 
               
Republic of Korea    
2008 14 800 – – – – – – – – – – – – – 
               
Thailand    
2005 – –  c – – – – – – – – – – – 
2007 – – – – – – – – – – – – – 45 965 
2008 – – 4 – – – – – – – – – – – 
    
Subregional total    
2004 12 349 10 000 10 199 0 0 0 0 5 332 23 387 0 13 100 000 2 1 741 5 519 
2005 13 529 0 38 425 0 276 000 0 0 3 435 1 230 0 168 000 0 0 0 
2006 3 527 0 6 678 0 0 0 0 0 0 0 0 0 0 0 
2007 6 256 0 6 425 0 0 0 0 0 0 0 0 5 0 45 965 
2008 21 128 0 7 770 0 0 0 0 0 2 857 0 0 2 1 100 0 
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South Asia    
India    
2004 2 665 – 72 – – – – – – – 91 400 – – – 
2005 300 – – – – – – – – – – – – – 
2006 133 – 1 226 – – – – – – – – – 50 – 
2007 236 – – – – – – – – – – – 290 – 
    
Subregional total    
2004 2 665 0 72 0 0 0 0 0 0 0 91 400 0 0 0 
2005 300 0 0 0 0 0 0 0 0 0 0 0 0 0 
2006 133 0 1 226 0 0 0 0 0 0 0 0 0 50 0 
2007 236 0 0 0 0 0 0 0 0 0 0 0 290 0 
2008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
West Asia               
Armenia               
2008 736 – – – – – – – – – – – – – 
               
Kazakhstan               
2005 2 – – – – – – – – – – – – – 
2006 4 – 31 – – – – – – – – – 27 – 
               
Kyrgyzstan               
2007 9 – – – – – – – – – – – – – 
               
Pakistan    
2005 – – – – – – – – – – – – 1 – 
2008 15 239 – – – – – – – – – – – – – 
               
Syrian Arab Republic    
2008 390 – – – – – – – – – – – – – 
               
Turkey               
2004 1 587 – – – – – – – – – – – – – 
2005 3 913 – – – – – – – 28 – – – – – 
2006 3 772 – – – – – – – 197 – – – – – 
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2007 13 303 – – – – – – – – – – – – – 
2008 10 553 – – – – – – – – – – – – – 
               
Uzbekistan               
2006 – – – – – – – – – – – º – – 
2007 – – – – – – – – – – – 8 – – 
               
Subregional total               
2004 1 587 0 0 0 0 0 0 0 0 0 0 0 0 0 
2005 3 915 0 0 0 0 0 0 0 28 0 0 0 0 0 
2006 3 776 0 31 0 0 0 0 0 197 0 0 0 27 0 
2007 13 312 0 0 0 0 0 0 0 0 0 0 8 0 0 
2008 26 918 0 0 0 0 0 0 0 0 0 0 0 0 0 
    
Europe               
States not members of the European Union          
Belarus               
2004 1 289 – º – – – – – 18 – – º – – 
2006 – – 1 – – – – – – – – – – – 
2008 º – – – – – – – – – – – – – 
Croatia    
2006d – – – – – – – 1 333 – – – – – – 
               
Iceland    
2005 – – 41 – – – – – – – – – – – 
               
Norway    
2004 – – – – – – – – – – – – – º 
2005 – – 1 – – – – – – – – – – – 
2006 – – 3 – – – – – – – – – – – 
2007 – – 4 – – – – – – – – – – – 
2008 – – º – – – – – – – – – – – 
               
Russian Federation    
2004 53 232 º 5 – – – – – – – – 901 – º 
2005 4 303 – 293 – – – 2 – – 2 – 1 306 2 – 
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2006 9 903 – 58 – – – – – 402 1 – 4 1 – 
2007 24 984 – 11 – – – 52 – 191 º – 195 º – 
2008 25 – 3 – – – 120 – 2 128 – – 10 – – 
               
Ukraine    
2004 2 – 3 – – – – – – – – 174 1 – 
2005 23 – 9 – – – – – – – – 9 º – 
2006 33 – 18 – – – – – – – – 81 º – 
2007 130 – º – – – – – – 18 – 1 352 478 – 
2008 400 – – – – – – – – – – 846 – 
               
European Union    
Austria     
2006 3 – – – – – – – – – – º – – 
2007 º – – – – – – – – – – – – – 
2008 1 – – – – – – – – – – 1 – – 
               
Belgium    
2004 – – – – – – – 3 199 – – – – – – 
2005 – – – – – – – 25 – – – – – – 
2006 – – 126 – – – – – – – – – – – 
2007 – – – – – – – – – – – – 250 – 
               
Bulgaria    
2004 7 042 – 20 – – – – – 15 – – – – – 
2005 2 – 86 – – – – – 1 – – 105 – – 
2006 38 – 3 – – – – – 32 – – – – – 
2007 – – 183 – – – – – – – – – – – 
2008 – – 43 – – – – – – – – – – – 
               
Czech Republic     
2004 – – 1 259 – – – – – – – – – º – 
2005 – – 27 – – – – – – – – – º – 
2006 – – 1 – – – – – – – – – º – 
2007 – – 1 – – – – – – – – – º – 
2008 – – 2 – – – – – – – – – 1 – 
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Denmark    
2006 – – – – – – – – 590 – – – – – 
               
Estonia    
2004 º – – – – – – 7 º – – º º – 
2005 º – – – – – – – 27 – – 1 – 7 
2006 º – – – – – – – 51 – – – – – 
2007 º – 7 – – – – – 98 – – – – – 
2008 – – – – – – – – 22 – – – – 1 841 
               
Finland     
2004 º – º – – – – – 1 – º º – – 
2005 – – e – – – – – – – – º – – 
2006 15 – – – – – – – 70 – – 2 – – 
2007 – – º – – – – – º – – – º – 
2008 – – – – – – – – – – – 2 – – 
               
France    
2004 – – º – – – – – – – – – – – 
2005 – – 5 – – – – 3 960 – – – – – – 
2006 º – 2 – – – º – – – – – – 7 
2007 – – 4 – – – – – – – – – 6 997 – 
2008 – – 6 – – – – – – – – – 502 – 
               
Germany    
2004 1 – – – – – – – – 6 – 3 – – 
2005 3 – 76 – – – – – 1 310 – – – – 26 
2007 º – º – – – – – 243 – – – – 4 
2008 2 – 55 – – – – – 1 – – – – – 
               
Greece    
2005 – – 1 088 – – – – – – – – – – – 
2007 – – – – – – – – – – – – – 3 
2008 – – – – – – – – – – – – – º 
               
Hungary    
2004 – – 10 – – – – – – – 6 100 – – – 
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2005 – – 15 – – – – – – – – – – – 
2006 – – 63 – – – – – – – – – – – 
2007 – – º – – – – – – – – – – – 
2008 63 616 – – – – – – – – – – – – – 
               
Ireland    
2004 – – – – – – – 34 26 – – – – – 
               
Italy    
2004 – – º – – – – – – – – – – – 
               
Latvia    
2004 – – 1 – – – – – – – – – – 100 
2005 – – º – – – – – – – – – – – 
               
Lithuania    
2004 – – – – – – – – 21 – – – – 22 
2005 – – – – – – – – 3 – – – – – 
2006 º – – – – – – – 4 – – – – – 
2007 – – – – – – – – – – – – – 1 
2008 – – – – – – – – 567 – – – – – 
               
Luxembourg    
2006 – – – – – – – – – – 100 3 º – 
               
Netherlands    
2004 – – – – – – – 6 280 4 220 – – – – – 
2005 – – – – – – – 1 162 340 – – – – – 
2006 – – – – – – – 105 174 – – – – – 
2007 – – 5 – – – – 20 – – – 5 094 – – 
2008 900 – 135 – – – – – – – – 1 975 – 60 
               
Poland    
2004 º – 3 – – – – – 4 996 – – – – – 
2006 – – – – – – – – 1 085 – – – – – 
2007 º – – – – – – – 241 – – – – – 
2008 160 – – – – – – – 39 – – – – – 
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Portugal    
2007 – – 2 – – – – – – – – º 1 – 
               
Romania    
2004 455 – 1 – – – – – – – 2 417 000 286 – – 
2005 43 – 35 – – – – – – – – 145 – – 
2006 87 – 1 – – – – – – – – 64 º – 
2007 1 206 – 1 – – – – – – – – 4 – – 
2008 – – º – – – – – – – – – – – 
               
Slovakia    
2004 – – 11 – – – – – – – – – º – 
2005 – – 2 – – – – – – – – – º – 
2006 – – 1 – – – – – – – – – – – 
2007 – – 1 – – – – – – – – – º – 
2008 – – 1 – – – – – – – – – – – 
               
Slovenia    
2007 6 472 – – – – – – – – – – – – – 
2008 86 118 – – – – – – – – – – – – – 
               
Spain    
2004 – – º – – – – – – – – 1 – – 
2005 – – – – – – – – – – – 3 – – 
2006 – – – – – º – – – – – – – – 
2007 – – – – – – – – – – – 7 – – 
2008 – – – – – – – – – – – 1 – – 
               
Sweden    
2007 – – 300 – – – – – – – – – – – 
2008 – – – – – – – – – – º – – – 
               
United Kingdom   
2004 – – 162 – – – – – – – – 10 – – 
2005 – – – – – – – – – – – 10 – – 
2006 3 – – – – – – – – – – 2 – – 
2007 – – 50 – – – – – – – – – – – 
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Regional total    
2004 62 021 0 1 475 0 0 0 0 9 520 9 297 6 2 423 100 1 375 1 122 
2005 4 374 0 1 678 0 0 0 2 5 147 1 681 2 0 1 579 2 33 
2006 10 081 0 277 0 0 0 0 1 438 2 407 1 100 156 1 7 
2007 32 794 0 569 0 0 0 52 20 773 18 0 6 652 7 726 8 
2008 151 223 0 245 0 0 0 120 0 2 757 0 0 2 835 503 1 901 
    
Oceania    
Australia    
2004 14 – 31 – – – – – – – 1 050 000 – 182 3 
2005 2 – 430 – – – 115 400 – – 2 000 000 º 81 – 
2006 – – 92 º 13 – – – – 3 7 – 159 50 
2007 12 – 167 – 32 255 113 1 907 º º – 1 159 7 
2008 – – 1 103 59 – 1 – – 3 – – – 37 – 
               
New Zealand    
2005 1 – 20 – – – – – – – – – 147 – 
2006 25 – º – – – – – – – – º 210 – 
2007 2 – º – – – – – – – – – – – 
2008 2 – 15 – – – – – – – – – – – 
               
Regional total    
2004 14 0 31 0 0 0 0 0 0 0 1 050 000 0 182 3 
2005 3 0 450 0 0 0 115 400 0 0 2 000 000 0 228 0 
2006 25 0 92 0 13 0 0 0 0 3 7 0 369 50 
2007 14 0 167 0 32 255 113 1 907 0 0 0 1 159 7 
2008 2 0 1 118 59 0 1 0 0 3 0 0 0 37 0 
               
World total    
2004 79 469 10 122 13 940 0 0 0 0 16 333 32 686 7 16 864 500 171 962 176 347 5 707 
2005 22 379 5 41 996 0 276 105 1 226 12 924 2 940 2 6 169 000 182 682 839 39 
2006 26 430 1 10 275 0 5 022 0 0 8 816 2 607 6 107 100 973 739 62 
2007 57 308 0 22 666 0 10 032 255 165 2 297 834 1 150 2 000 010 153 281 24 956 45 986 
2008 199 344 5 12 638 59 0 1 120 0 5 620 0 1 383 000 45 776 5 133 1 904 
 E/IN
C
B/2009/447
 
 a 3,4-Methylenedioxyphenyl-2-propanone. 
 b For statistical purposes, the data for China do not include those for the Hong Kong Special Administrative Region (SAR) of China, Macao SAR of China and 
Taiwan Province of China. 
 c Thailand reported a seizure of 95 tablets of ephedrine for 2005. 
 d Reported to the International Narcotics Control Board by the Permanent Mission of Croatia to the United Nations (Vienna) in May 2007. 
 e Finland reported 3,042 tablets of 50 mg of ephedrine, 1,705 tablets of 30 mg ephedrine, 300 tablets of 8 mg ephedrine and 192 tablets of 25 mg ephedrine for 
2005. 
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Africa 
South Africa 
2004 261 20 – 70 – – – 215 421 
2005 161 – 5 224 – – – 163 197 
2006 319 – 2 286 – – – 173 524 
2007 369 – – 1 038 – – – 413 615 
 
Regional total 
2004 261 20 0 70 0 0 0 215 421 
2005 161 0 5 224 0 0 0 163 197 
2006 319 0 2 286 0 0 0 173 524 
2007 369 0 0 1 038 0 0 0 413 615 
2008 0 0 0 0 0 0 0 0 0 
  
Americas  
          
Central America  
Panama  
2007 – – – 1 041 – – – – – 
          
El Salvador  
2006 – – – 412 500 – – – – – 
  
Subregional total  
2004 0 0 0 0 0 0 0 0 0 
2005 0 0 0 0 0 0 0 0 0 
2006 0 0 0 412 500 0 0 0 0 0 
2007 0 0 0 1 041 0 0 0 0 0 
2008 0 0 0 0 0 0 0 0 0 
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North America          
Canada          
2004 8 – – – – – – 20 4 
2006 120 – – 278 – 21 º 171 184 
2007 142 – 7 41 4 3 – – 448 
2008 1 235 – – 36 – – – 1 906 
          
Mexico          
2005 538 – 1 200 78 – 15 000 – 9 1 295 
2007 1 492 – 62 721 – – – 18 1 765 
2008 8 674 – 447 14 102 1 002 – – 6 004 425 
          
United States          
2004 1 953 047 – 198 364 56 168 296 540 7 13 523 570 22 717 
2005 44 326 – 839 11 414 1 835 925 4 446 845 2 443 
2006 9 530 – 1 190 30 266 111 – 4 3 069 179 4 020 
2007 6 931 – 1 420 3 888 154 º º 1 406 5 197 
2008 4 114 – 2 817 3 411 279 1 180 2 180 6 206 
          
Subregional total          
2004 1 953 055 0 198 364 56 168 296 540 7 13 523 590 22 721 
2005 44 864 0 2 039 11 492 1 835 15 925 4 446 854 3 738 
2006 9 650 0 1 190 30 544 111 21 4 3 069 350 4 204 
2007 8 565 0 1 489 4 650 158 3 0 1 424 7 410 
2008 14 023 0 3 264 17 549 1 281 1 180 8 185 7 537 
          
South America          
Argentina          
2004 2 071 1 220 60 707 – – – 50 709 54 792 
2005 2 000 – – 3 854 – – – 29 172 – 
2006 668 – 45 42 000 – – – 6 – 
2007 1 086 – 108 401 35 802 – – 28 957 – 
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Bolivia          
2004 3 608 – – 23 728 – – – 82 308 2 203 
2005 2 362 – – 19 419 – – – 22 010 925 
          
Brazil          
2004 288 – 63 214 – – – – – 
2005 – – 102 2 500 3 006 – – 272 863 1 325 
2006 512 – 306 8 562 1 512 – – 12 5 964 
2007 1 040 – 32 1 195 6 – – 5 315 14 
          
Chile          
2005 600 – – 5 – – – 282 – 
2006 220 – – – – – – 14 958 – 
2008 95 – – 400 – – – 1 593 – 
          
Colombia          
2004 1 222 411 – 105 398 214 303 11 120 – – 394 487 59 178 
2005 1 218 468 – 54 235 182 736 14 822 – – 394 148 22 746 
2006 1 467 242 – 23 259 286 532 60 818 – – 1 321 764 26 587 
2007 1 207 105 – 33 410 519 122 103 838 – – 524 653 43 346 
2008 1 468 212 68 228 313 312 21 359 305 755 27 
          
Ecuador          
2004 – – – 475 16 850 – – 84 – 
2005 20 – – 147 9 179 – – 4 071 8 
2006 – – – – 28 550 – – – – 
2007 – – – 443 500 – – 200 – 
2008 – – 60 423 6 927 – – 143 449 
          
Paraguay          
2006 200 – – 10 – – – – – 
          
Peru          
2004 13 087 – – 36 691 9 – – 20 610 1 620 
2005 20 398 – – 36 914 – – – 28 425 3 908 
2006 8 444 – – 24 303 – – – 6 309 216 
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2007 84 549 – 12 800 33 433 – – – 33 107 220 
2008 29 864 – 150 75 963 – – – 30 776 3 318 
          
Subregional total          
2004 1 241 465 1 105 681 336 118 27 979 0 0 548 198 117 793 
2005 1 243 848 0 54 337 245 575 27 007 0 0 750 971 28 912 
2006 1 477 286 0 23 610 361 407 90 880 0 0 1 343 049 32 766 
2007 1 293 780 0 46 350 554 594 140 146 0 0 592 232 43 580 
2008 1 498 171 0 68 438 390 098 28 286 0 0 338 267 3 794 
  
Asia          
          
East and South-East Asia          
Cambodia          
2007 702 – – – – – – – – 
          
Chinaa          
2004 9 708 – 9 877 11 907 – – – 1 090 7 277 
2005 7 004 14 14 863 5 789 – 31 803 2 1 466 34 350 
2006 97 111 – 19 088 420 700 – – – 328 855 46 939 
2007 51 737 – 90 013 126 716 – – – 93 619 69 335 
2008 82 232 – 11 687 405 671 – – – 238 215 11 781 
          
 Hong Kong SAR          
2004 30 – 5 5 – – – – – 
2005 – – – 3 – – – – – 
          
 Macao SAR          
2005 – – – 7 – – – – – 
2006 69 – – – – – – – – 
          
Indonesia          
2005 165 – – 325 – – – – – 
2008 183 – – 110 5 – – 5 105 
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Myanmar          
2004 1 500 – 6 255 2 068 – – – – – 
2007 163 – 2 814 75 – – – – – 
2008 – – 352 128 – – – 32 – 
          
Philippines          
2004 9 893 – – 2 12 – – 73 9 600 
2005 2 685 – – – – – – – – 
2007 – – – 320 – – – – – 
2008 902 – – 385 – – – – – 
          
Thailand          
2005 – – – – – – – 73 – 
2006 – – – – – – – 54 – 
          
Subregional total          
2004 21 131 0 16 137 13 982 12 0 0 1 163 16 877 
2005 7 169 14 14 863 6 124 0 31 803 2 1 539 34 350 
2006 97 180 0 19 088 420 700 0 0 0 328 909 46 939 
2007 52 602 0 92 827 127 111 0 0 0 93 619 69 335 
2008 83 317 0 12 039 406 294 5 0 0 238 252 11 886 
          
South Asia          
India           
2004 – 2 700 – – – – – – 1 800 
2006 – 650 – – – – – – – 
          
Maldives          
2008 – – – – – – – 10 860 – 
          
Subregional total          
2004 0 2 700 0 0 0 0 0 0 1 800 
2005 0 0 0 0 0 0 0 0 0 
2006 0 650 0 0 0 0 0 0 0 
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2007 0 0 0 0 0 0 0 0 0 
2008 0 0 0 0 0 0 0 10 860 0 
          
West Asia          
Kazakhstan          
2005 9 – – 76 – – – 61 – 
2006 48 – – 12 – – – 1 978 413 
          
Kyrgyzstan          
2006 – – – – – – – 231 – 
2007 – – – – – – – 346 – 
2008 – – – – – – – 2 983 – 
          
Lebanon          
2004 – – 300 5 – – – – – 
2005 40 – – – – – – – – 
2006 10 – 3 3 – – – – – 
2007 º – 1 º – – – – – 
2008 1 – 1 – – – – – – 
          
Pakistan          
2008 15 – – – – – – – – 
          
Tajikistan          
2007 – – – – – – – 1 007 – 
          
Turkey          
2004 – – 30 – – – – – – 
2006 4 081 – – 168 2 – – – – 
2007 280 – 530 – – – – – – 
2008 º – – – – – – – – 
          
Uzbekistan          
2006 – – – 120 – – – 542 – 
2007 º – – 60 – – – 3 132 – 
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Subregional total          
2004 0 0 330 5 0 0 0 0 0 
2005 40 0 0 0 0 0 0 0 0 
2006 4 139 0 3 302 2 0 0 2 751 413 
2007 280 0 531 60 0 0 0 4 485 0 
2008 17 0 1 0 0 0 0 2 983 0 
Europe          
States not members of the European Union       
Albania          
2007 13 – 10 5 – – – – – 
          
Belarus          
2004 30 276 – 4 40 000 – – – 10 045 1 
2005 61 – – – – – – 560 18 
2006 905 – – – – – – 74 700 – 
2007 4 020 – – – – – – – 558 
2008 3 – – – – – – – – 
          
Iceland          
2005 – – – – – º – º – 
          
Norway          
2004 – – – 15 – – – – – 
          
Russian Federation          
2004 2 783 – 130 59 133 1 – – 104 1 767 
2005 40 244 – 6 428 299 573 216 – – 668 741 2 093 
2006 64 502 – 809 219 734 – – – 255 587 80 205 
2007 31 067 – 1 314 168 133 5 – 2 132 406 5 165 
2008 5 214 – 477 4 296 – – – 1 598 725 
          
Ukraine          
2004 1 443 – 5 2 232 125 – – 1 178 97 351 
2005 1 846 – – 3 485 2 320 – – 224 11 090 
2006 1 249 – 128 8 181 2 036 – – 56 060 4 065 
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2007 6 605 6 3 135 349 115 – – 79 609 5 269 
2008 17 009 109 – – 778 855 006 – – – 62 120 858 10 314 
  
European Union           
Austria          
2006 1 – – 3 – º – 1 2 
2007 – – – 1 – – – 1 º 
2008 1 – – 2 – – – 12 5 
          
Belgium           
2004 – – – – – 55 – – – 
2005 19 400 – – 8 650 – – – – – 
2006 2 890 – – 125 – – – 5 – 
2007 78 – 62 1 256 – – – 173 22 
2008 1 510 – – 1 850 – – – – – 
          
Bulgaria          
2004 – – – 4 – – – – 17 
2005 204 – º 6 – º – 3 – 
2006 – – – – – 500 – – – 
2007 – – – – – 50 – – – 
2008 – – – – – 153 – – – 
          
Czech Republic          
2005 – – – – – – – – 1 
2007 – – – 4 – – – º 10 
2008 – – – – – – – – 17 
          
Estonia          
2004 º º 22 60 – – – 5 – 
2005 º – º º – – – 15 10 
2006 – – – – – – – 4 2 
2007 – – – – – – – 15 2 
2008 – – – º – – – º – 
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Finland          
2004 5 – – 2 – – – 2 – 
2006 – – – 23 1 – – 2 – 
2008 12 – 1 23 – – – – – 
          
France          
2007 987 – – – – – – – – 
          
Germany           
2004 2 – 21 2 – – – 1 5 
2005 4 – – 13 – – – 4 3 
2006 6 – 6 8 – – – 3 6 
2007 3 – – 803 – – – 62 13 
2008 2 – 3 8 – – – 3 11 
          
Greece          
2007 – – – – – – – 3 º 
          
Hungary          
2004 – – – – – 1 – – – 
2007 º – 1 2 – – – 1 – 
          
Italy           
2004 23 – 25 3 – – – 2 – 
2005 – – – 5 – – – – – 
          
Lithuania          
2006 – – – – – – – 10 – 
2007 – – – – – 106 – – – 
2008 10 – – 20 – – – 20 – 
          
Luxembourg          
2006 835 – – 100 889 – 4 – 88 
          
Netherlands           
2004 9 775 – – 780 – 48 – – – 
2005 19 040 – – 4 205 – – – – – 
2006 3 458 – 1 690 8 134 – – – 47 – 
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2007 15 211 – 1 400 5 546 – – – 1 375 29 
2008 6 631 – 30 3 971 9 – – 770 400 
          
Poland          
2004 – – – 705 – 120 – 54 3 
2006 2 – – 76 – – – 19 17 
2007 – – – 145 – – – 12 º 
2008 – – – 231 – – – 31 20 
          
Portugal           
2007 37 – 40 6 – – – 5 9 
          
Romania          
2004 – 1 – – – – – – – 
2005 125 3 14 – 26 – 10 810 72 
2006 338 3 2 11 – º 51 294 10 
2007 – – 6 500 – º – 1 591 º 
          
Slovakia          
2004 º – – 20 – – – º 9 
2005 16 – – 9 – – – º 63 
2006 – – – 8 – – – – 62 
2007 2 – – 6 – – – – 67 
2008 4 – – 24 – – – 1 88 
          
Spain           
2004 59 – 1 40 2 1 7 1 9 
2005 1 197 – 5 12 131 4 – 10 – 
2006 401 – 37 15 205 – – – – 
2007 567 – 72 57 872 – – 259 1 
2008 862 – 104 77 2 083 – – 106 1 
          
United Kingdom        
2006 5 – 5 9 – – – 13 8 
2007 – – – 2 – – – 2 5 
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Regional total          
2004 44 366 1 208 102 996 128 225 7 11 392 99 162 
2005 82 137 3 6 447 315 958 2 693 4 10 670 367 13 350 
2006 74 592 3 2 676 236 432 3 130 500 55 386 745 84 528 
2007 58 588 6 2 906 311 814 992 156 2 215 512 11 151 
2008 17 023 358 0 615 778 865 508 2 092 153 0 62 123 399 11 581 
          
Oceania          
Australia          
2004 304 – 23 175 37 – – 51 164 
2005 372 – 73 375 5 º – 398 982 
2007 202 – 1 274 271 3 – – 29 275 
2008 – – – – – 1 – – – 
          
New Zealand           
2005 102 – 1 41 2 – – 33 581 
2006 321 – 218 491 73 – – 168 1 540 
2007 249 – – 233 59 – – 195 1 009 
2008 291 – 5 235 32 – – 56 643 
Regional total  
         
2004 304 0 23 175 37 0 0 51 164 
2005 474 0 74 416 7 0 0 431 1 563 
2006 321 0 218 491 73 0 0 168 1 540 
2007 451 0 1 274 504 62 0 0 225 1 284 
2008 291 – 5 235 32 1 – 56 643 
World total 
         
2004 3 260 582 2 722 320 743 56 621 642 28 696 232 20 1 084 609 258 938 
2005 1 378 693 17 77 765 579 789 31 542 47 732 16 1 870 325 82 110 
2006 1 663 487 653 46 787 1 462 662 94 196 521 59 5 131 145 170 914 
2007 1 414 635 6 145 377 1 000 812 141 358 159 2 907 910 133 375 
2008 18 619 177 0 84 362 779 679 684 31 696 155 180 62 722 002 35 441 
          
 a For statistical purposes, the data for China do not include those for the Hong Kong Special Administrative Region (SAR) of China, Macao SAR of China and 
Taiwan Province of China. 
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Annex IV 
 
 
  Submission of information by Governments on licit trade in 
and legitimate uses of and requirements for substances in 
Tables I and II of the 1988 Convention for the  
years 2004-2008 
 
 
 Governments of the countries and territories indicated have provided 
information on licit trade in, uses of and requirements for substances in Tables I  
and II of the United Nations Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 on form D for the years 2004-2008. That 
information was requested in accordance with Economic and Social Council 
resolution 1995/20 of 24 July 1995. Details may be made available on a case-by-
case basis, subject to confidentiality of data. 
Notes:  The names of non-metropolitan territories and special administrative regions are in 
italics.  
  X signifies that relevant information was submitted on form D. 
 
 
  2004 2005 2006 2007 2008 
Country or territory Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments 
Afghanistan                   X X 
Albania         X X    X 
Algeria   X X X X   X X X X 
Andorra                     
Angola                   X X 
Anguilla                     
Antigua and Barbuda                   
Argentina   X X X X X X X X   
Armenia   X X X X   X X X X 
Aruba                     
Ascension Island X X X X X X   X X 
Australia   X X X X X X X  X X 
Austriaa   X X X X X X X X X X 
Azerbaijan       X     X X X X 
Bahamas             X       
Bahrain             X     
Bangladesh   X X X X X X X X X X 
Barbados   X X               
Belarus   X X X X X X X X X X 
Belgiuma   X   X     X X   
Belize                     
Benin   X X X X   X X X X 
Bermuda                     
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Uses 
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require- 
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Bhutan             X X   
Bolivia  X X X X X    X X 
Bosnia and Herzegovina          X X X X 
Botswana                     
Brazil   X X X X X X X X X X 
British Virgin Islands                   
Brunei Darussalam X X X X   X X  X 
Bulgariaa   X X X X X X X X X X 
Burkina Faso                     
Burundi                     
Cambodia   X X X X X X X X   
Cameroon                     
Canada   X X X X X X X X   
Cape Verde                     
Cayman Islands                   
Central African Republic                   
Chad                     
Chile   X X X  X X X X X X 
China   X   X      X   X  
 Hong Kong SAR X X X X X X X X X X 
 Macao SAR   X X X X X X X X X X 
Christmas Island                 X X 
Cocos (Keeling) Islands                   
Colombia   X X X X X X X X X X 
Comoros                     
Congo   X X             X X 
Cook Islands   X X X X X X   X  
Costa Rica   X X X X X X X X X X 
Côte d’Ivoire                X  X X 
Croatia       X  X   X X  X X 
Cuba                 X X X X 
Cyprusa   X X X X   X X X X 
Czech Republica X X X X X X X X X X 
Democratic People’s 
Republic of Korea      X X  X X X X X 
Democratic Republic 
of the Congo        X X X X X X 
Denmarka   X X X X   X X X X 
Djibouti                     
Dominica                     
Dominican Republic X X    X X  X X X 
Ecuador   X X X X X X X X X X 
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Egypt   X X X X X X X X X X 
El Salvador   X X X X X X X X X X 
Equatorial Guinea                   
Eritrea                     
Estoniaa   X X X X   X X X X 
Ethiopia   X X X X X X X X X X 
Falkland Islands (Malvinas) X X X X X X X X X X 
Fiji                     
Finlanda       X X   X X X X 
Francea   X   X    X   X  
French Polynesia                   
Gabon                     
Gambia                     
Georgia   X X X X X X X X X X 
Germanya   X   X X   X X X X 
Ghana                   
Gibraltar                     
Greecea   X X X X   X X X X 
Grenada                     
Guatemala   X X           X  X 
Guinea                     
Guinea-Bissau                      
Guyana       X X   X X X X 
Haiti   X X X X X X X X X X 
Honduras             X X   
Hungarya   X X X X X X X X   
Iceland       X X X X X X X X 
India   X X X X   X X   
Indonesia   X X X X X X X X X  
Iran (Islamic Republic of)          X X X X X X 
Iraq                   X X 
Irelanda    X X X X X X X X X X 
Israel                     
Italya   X   X  X X X X X X 
Jamaica   X X X X X X X X X X 
Japan   X X X X X X X X X X 
Jordan   X X X X X X X X X X 
Kazakhstan       X X X  X X   
Kenya   X X             X X 
Kiribati                     
Kuwait                       
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Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments 
Kyrgyzstan   X X X X X X X X X X 
Lao People’s Democratic 
Republic  X   X     X     
Latviaa   X X X X X X X X X X 
Lebanon    X X X X X X X X X X 
Lesotho                     
Liberia                     
Libyan Arab Jamahiriya            
Lithuaniaa   X X X X   X X   
Luxembourga       X         X  
Madagascar       X X     X X 
Malawi        X   X X   
Malaysia       X X     X X 
Maldives   X X               
Mali                     
Maltaa   X X X X X X X X X X 
Marshall Islands                   
Mauritania                     
Mauritius   X X X X   X X   
Mexico   X X X X X X X X X X 
Micronesia (Federated 
States of)  X X X X       
Monaco       X X   X X   
Mongolia                     
Montenegrob       X X X X 
Montserrat   X X   X   X   X   
Morocco   X X X X   X X X X 
Mozambique         X X     
Myanmar   X X X X X X X X X X 
Namibia         X X     
Nauru                     
Nepal                     
Netherlandsa   X X X X   X X X X 
Netherlands Antilles     X X X X X X X X 
New Caledonia   X   X  X X     
New Zealand   X X X X X X X X X X 
Nicaragua   X X X X X X X X X X 
Niger                     
Nigeria   X X X X       
Norfolk Island             X X   
Norway   X X X X X X X X X X 
Oman         X       X  
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  2004 2005 2006 2007 2008 
Country or territory Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments 
Pakistan   X X X X   X X X X 
Palau                     
Panama   X X X X X X X X X X 
Papua New Guinea           X X   
Paraguay                   X X 
Peru   X X X X X X X X X X 
Philippines   X X X X  X X  X X 
Polanda   X X X X X X X X   
Portugala   X   X  X  X  X  
Qatar                     
Republic of Korea X X X    X X X X 
Republic of Moldovac X X X X X X X X X X 
Romaniaa   X X X X X X X X X X 
Russian Federation X X X X   X X X X 
Rwanda                     
Saint Helena     X   X   X X X X 
Saint Kitts and Nevis                   
Saint Lucia              X   X X 
Saint Vincent and the 
Grenadines      X X X X     
Samoa                     
San Marino                     
Sao Tome and Principe        X X     
Saudi Arabia   X   X  X   X   X  
Senegal   X X X  X X     
Serbiad        X X X X 
Seychelles   X X             X X 
Sierra Leone                     
Singapore   X X X X X X X X X X 
Slovakiaa   X X X X   X X X X 
Sloveniaa   X X X X X X X X X X 
Solomon Islands                   
Somalia                     
South Africa   X X X X   X X   
Spaina   X X X X X X X X X X 
Sri Lanka   X X X X X X X X   
Sudan         X X     
Suriname                     
Swaziland                      
Swedena   X X X X   X X X X 
Switzerland   X X X X   X X X X 
Syrian Arab Republic X X X X X X X X X X 
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  2004 2005 2006 2007 2008 
Country or territory Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments Trade 
Uses 
and/or 
require- 
ments 
Tajikistan     X  X   X    
Thailand   X X X X   X X X X 
The former Yugoslav 
Republic of Macedonia                   
Timor-Leste            
Togo                     
Tonga         X X     
Trinidad and Tobago X X X X X  X X X X 
Tristan da Cunha       X          
Tunisia   X X X X X X X X X X 
Turkey     X X X X X X X X   
Turkmenistan      X      X X X  
Turks and Caicos Islands           
Tuvalu                     
Uganda   X X   X X X X X X 
Ukraine   X X X X X X X X X X 
United Arab Emirates X X X X   X X X X 
United Kingdoma     X    X X X X 
United Republic of 
Tanzania  X X               
United States of America  X X X X   X X X X 
Uruguay             X X   
Uzbekistan   X X X X   X X X X 
Vanuatu       X X     
Venezuela (Bolivarian 
Republic of)     X  X  X X  X 
Viet Nam   X X X X   X X X X 
Wallis and Futuna Islands            
Yemen    X   X  X X X X X  
Zambia   X X X X X X X X   
Zimbabwe                       
Total number of 
Governments that 
submitted form D 104 97 109 97 80 74 115 107 108 101 
Total number of 
Governments requested 
to provide information 212 212 212 212 213 213 213 213 213 213 
 
 a State member of the European Union. 
 b By its resolution 60/264 of 28 June 2006, the General Assembly decided to admit Montenegro to membership in the United 
Nations. 
 c Since 9 September 2008, “Republic of Moldova” has replaced “Moldova” as the short name used in the United Nations. 
 d Following the Declaration of Independence by the National Assembly of Montenegro on 3 June 2006, the President of the 
Republic of Serbia notified the Secretary-General that the membership of the state union Serbia and Montenegro in the United 
Nations, including all organs and organizations of the United Nations system, was continued by the Republic of Serbia, which 
remained responsible in full for all the rights and obligations of the state union Serbia and Montenegro under the Charter of the 
United Nations. Since 3 June 2006, the Republic of Serbia has aced in the United Nations under the designation “Serbia”. 
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Annex V 
 
 
  Annual legitimate requirements for ephedrine, 
pseudoephedrine, 3,4-methylenedioxyphenyl-2-propanone 
and 1-phenyl-2-propanone, substances frequently used in 
the manufacture of amphetamine-type stimulants 
 
 
1. In its resolution 49/3, entitled “Strengthening systems for the control of 
precursor chemicals used in the manufacture of synthetic drugs”, the Commission 
on Narcotic Drugs, inter alia:  
 (a) Requested Member States to provide to the International  
Narcotics Control Board annual estimates of their legitimate requirements  
for 3,4-methylenedioxyphenyl-2-propanone (3,4-MDP-2-P), pseudoephedrine, 
ephedrine and 1-phenyl-2-propanone (P-2-P) and, to the extent possible, estimated 
requirements for imports of preparations containing those substances that could be 
easily used or recovered by readily applicable means; 
 (b) Requested the Board to provide those estimates to Member States in such 
a manner as to ensure that such information was used only for drug control 
purposes; 
 (c) Invited Member States to report to the Board on the feasibility and 
usefulness of preparing, reporting and using estimates of legitimate requirements for 
the precursor chemicals and preparations referred to above in preventing diversion. 
2. Pursuant to that resolution, the Board formally invited Governments to prepare 
estimates of their legitimate requirements for those substances. Those estimates, as 
reported by Governments, were published, for the first time, in March 2007. 
3. The table below reflects the latest data reported by Governments on those four 
precursor chemicals (and their preparations, as relevant). It is expected that those 
data will provide the competent authorities of exporting countries with at least an 
indication of the legitimate requirements of importing countries, thus preventing 
diversion attempts. Governments are invited to review their requirements as 
published, amend them as necessary and inform the Board of any required change. 
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  Annual legitimate requirements reported by Governments for ephedrine, 
pseudoephedrine, 3,4-methylenedioxyphenyl-2-propanone, 1-phenyl-2-propanone 
and their preparations  
(Kilograms) 
Country or territory Ephedrine 
Ephedrine 
preparations Pseudoephedrine 
Pseudoephedrine 
preparations 3,4-MDP-2-Pa P-2-Pb 
Afghanistan 50 0 5 000 0 0 0 
Albania 1      
Algeria 10  17 000    
Argentina 156  9 700   1 
Australia 5 15 9 000 1 250  40 
Austria 130 67 1 1 1 1 
Azerbaijan 20  10    
Bangladesh 368  49 021    
Barbados 250  160    
Belarus  60 50  1 1 
Belgium 250  21 000  0 200 
Belize   P P   
Benin    10     
Bosnia and 
Herzegovina 20  1 500  0 0 
Botswana 300         
Brazil 2 200  12 160  0 3 807 
Bulgaria 50        
Cambodia 200 50 300 900     
Canada 2 000 5 20 000  0 0 
Chile 270   6 800  0 0 
China 140 000  110 000    
 Hong Kong SAR  4 500 0 4 300 0 0 0 
 Macao SAR 1 10 1 159 0 0 
Colombia 26  20 393    
Cook Islands  1     
Costa Rica 1  918  0 0 
Côte d’Ivoire 31 1 0 0 0 0 
Croatia 100  400    
Cuba 140   5    
Cyprus   100    
Czech Republic 660 14 2 300 2 000 0 1 
Democratic People’s 
Republic of Korea 2 300    10  
Democratic Republic 
of the Congo 250  900    
Dominican Republic 100   500   
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Country or territory Ephedrine 
Ephedrine 
preparations Pseudoephedrine 
Pseudoephedrine 
preparations 3,4-MDP-2-Pa P-2-Pb 
Ecuador 100  7 500       
Egypt 2 000  58 000 2 000     
El Salvador 10 5 0      
Estonia 6           
Falkland Islands 
(Malvinas)  1  1     
Finland 100     1 000   5 
Georgia 100 25 50 25     
Germany 8 000   20 000   1 3 046 
Ghana 2 000   700       
Greece 50   320       
Guinea 36           
Guinea-Bissau 0 0 0 0 0 0 
Guyana    85       
Haiti 150   360   0 0 
Honduras 150      
Hungary 800   0 0 300 1 421 
Iceland 1   1       
India   0 0   0 
Indonesia 12 058   29 452       
Iran (Islamic 
Republic of) 50 1 55 000 10 6 51 
Iraq 3 000   12 000       
Ireland 1 1 1 863 0 0 
Israel 43   2 130 1 905     
Italy 200   9 000     450 
Jamaica       0 0 
Japan 210   10 000       
Jordan 1 650   20 000     60 500 
Kazakhstan 818   1       
Kenya 3 000  3 500    
Kyrgyzstan 0   20   0 0 
Latvia 25 27 41 383     
Lebanon 1  150  0 0 
Lithuania   1   600     
Madagascar 702  150    
Malawi 1 000          
Malaysia 410 0 15 625 1 500 0 0 
Malta   220   220 1 1 
Mauritius 0 0 0 0 0 0 
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Country or territory Ephedrine 
Ephedrine 
preparations Pseudoephedrine 
Pseudoephedrine 
preparations 3,4-MDP-2-Pa P-2-Pb 
Mexico P P P P   
Monaco 0 0 0 0 0 0 
Mongolia 1      
Montenegro  1  1   
Montserrat  1  1   
Morocco 1 0 1 024 0 0 0 
Mozambique 3      
Myanmar 3           
New Zealand 50   650       
Nicaragua   200    
Nigeria 3 849  5 823    
Norway 300         1 
Pakistan 22 000   48 000       
Panama 25 30 2 500 2 500     
Papua New Guinea 1   200   0 0 
Peru 39   2 494 1 425     
Philippines  61  112  0 0 
Poland 100   3 600       
Portugal     15       
Republic of Korea 15 950   32 500       
Republic of Moldova  10  150     
Romania 192  4 575      
Russian Federation 1 500           
Saint Helena  1  1     
Sao Tome and Principe 0 0 0 0 0 0 
Serbia 55   600       
Slovakia 3 1 1 0 0 0 
Slovenia 3   350       
Solomon Islands 0 1 0 1 0 0 
South Africa 20 000 0 20 000 0 0 0 
Spain 1 154   7 005   0  
Sri Lanka     0  
Sweden 177   1   1 25 
Switzerland        0   
Syrian Arab Republic 1 000   50 000       
Tajikistan 38           
Thailand 16   36 900       
Turkey 2 000   23 000       
Uganda 200 1 2 000 6     
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Country or territory Ephedrine 
Ephedrine 
preparations Pseudoephedrine 
Pseudoephedrine 
preparations 3,4-MDP-2-Pa P-2-Pb 
United Arab Emirates 200  2 000       
United Kingdom 3 335  6 918  3 0 
United Republic of 
Tanzania 950   500       
United States of 
America 140 260   511 100   0 46 803 
Uruguay    22       
Venezuela (Bolivarian 
Republic of) 1 000   20 000       
Yemen   5 000    
Zambia 5  10    
 
Notes: The names of territories and special administrative regions are in italics. 
  A blank field signifies that no requirement was indicated or that data were not submitted for the 
substance in question. 
  A zero (0) signifies that the country or territory has no licit requirement for the substance. 
  Reported quantities of less than 1 kg have been rounded up and are reflected as 1 kg. 
  The letter “P” signifies that importation of the substance is prohibited. 
 a 3,4-Methylenedioxyphenyl-2-propanone. 
 b 1-Phenyl-2-propanone. 
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Annex VI 
 
 
  Governments that have requested pre-export  
notifications pursuant to article 12, paragraph 10 (a),  
of the 1988 Convention 
 
 
1. The Governments of all exporting countries and territories are reminded that it 
is an obligation to provide pre-export notifications to Governments that have 
requested them pursuant to article 12, paragraph 10 (a), of the United Nations 
Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 
1988, which provides that: 
 “... upon request to the Secretary-General by the interested Party, each Party 
from whose territory a substance in Table I is to be exported shall ensure that, 
prior to such export, the following information is supplied by its competent 
authorities to the competent authorities of the importing country: 
  “(i) Name and address of the exporter and importer and, when 
available, the consignee; 
  “(ii) Name of the substance in Table I; 
  “(iii) Quantity of the substance to be exported; 
  “(iv) Expected point of entry and expected date of dispatch; 
  “(v) Any other information which is mutually agreed upon by the 
Parties.” 
2. Governments that have requested pre-export notifications under the above 
provisions are listed in the table below in alphabetical order, followed by the 
substance (or substances) to which the provisions apply and the date of notification 
of the request transmitted by the Secretary-General to Governments. 
3. Governments may wish to note the possibility of requesting that a pre-export 
notification for all substances listed in Table II of the 1988 Convention be sent as 
well. 
 
Notifying Government 
Substances to which pre-export notification requirement 
applies 
Date of communication to Governments 
by the Secretary-General 
Antigua and Barbudaa All substances included in Tables I and II 5 May 2000 
Argentina All substances included in Table I 19 November 1999 
Australia Ephedrine, pseudoephedrine 26 June 2000 
Austria All substances included in Table I 19 May 2000 
Belarusb Acetic anhydride, ephedrine, potassium 
permanganate and pseudoephedrine 
 
Belgium All substances included in Table I 19 May 2000 
Benina All substances included in Tables I and II  4 February 2000 
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Notifying Government 
Substances to which pre-export notification requirement 
applies 
Date of communication to Governments 
by the Secretary-General 
Bolivia (Plurinational State 
of)a, c 
Acetic anhydride, acetone, ethyl ether, hydrochloric 
acid, potassium permanganate and sulphuric acid 
12 November 2001 
Brazila All substances included in Tables I and II 15 October 1999 and  
15 December 1999 
Bulgaria All substances included in Table I 19 May 2000 
Canada All substances included in Tables I and II 31 October 2005 
Cayman Islandsa All substances included in Tables I and II 7 September 1998 
China Acetic anhydride 20 October 2000 
 Macao SARd All substances included in Table I 19 May 2000 
Colombiaa All substances included in Tables I and II 14 October 1998 
Costa Ricaa All substances included in Table I 
All substances included in Table II 
27 September 1999 
31 January 2005 
Cyprus All substances included in Table I 19 May 2000 
Czech Republic All substances included in Table I 19 May 2000 
Denmark All substances included in Table I 19 May 2000 
Dominican Republica All substances included in Table II  11 September 2002 
Ecuadora All substances included in Tables I and II 1 August 1996 
Egypta All substances included in Table I and acetone 3 December 2004 
Estonia All substances included in Table I 19 May 2000 
Ethiopiaa All substances included in Tables I and II 17 December 1999 
Finland All substances included in Table I 19 May 2000 
France All substances included in Table I 19 May 2000 
Germany All substances included in Table I 19 May 2000 
Greece All substances included in Table I 19 May 2000 
Haitia All substances included in Tables I and II 20 June 2002 
Hungary All substances included in Table I 19 May 2000 
Indiaa All substances included in Tables I and II 23 March 2000 
Indonesiaa Acetic anhydride, N-acetylanthranilic acid, 
anthranilic acid, ephedrine, ergometrine, 
ergotamine, isosafrole, 3,4-methylenedioxyphenyl-
2-propanone, norephedrine, phenylacetic acid, 
1-phenyl-2-propanone, piperonal, potassium 
permanganate, pseudoephedrine and safrole 
18 February 2000 
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Notifying Government 
Substances to which pre-export notification requirement 
applies 
Date of communication to Governments 
by the Secretary-General 
Ireland All substances included in Table I 19 May 2000 
Italy All substances included in Table I 19 May 2000 
Japan N-Acetylanthranilic acid, ephedrine, ergometrine, 
ergotamine, isosafrole, lysergic acid, 
3,4-methylenedioxyphenyl-2-propanone, 
1-phenyl-2-propanone, piperonal, pseudoephedrine 
and safrole 
17 December 1999 
Jordana All substances included in Tables I and II 15 December 1999 
Kazakhstana All substances included in Tables I and II 15 August 2003 
Latvia All substances included in Table I 19 May 2000 
Lebanona All substances included in Tables I and II 14 June 2002 
Lithuania All substances included in Table I 19 May 2000 
Luxembourg All substances included in Table I 19 May 2000 
Madagascara All substances included in Tables I and II 31 March 2003 
Malaysiaa All substances included in Table I, anthranilic acid, 
ethyl ether, phenylacetic acid and piperidine  
21 August 1998 
Maldivesa All substances included in Tables I and II 6 April 2005 
Malta All substances included in Table I 19 May 2000 
Mexicoa All substances included in Tables I and II 6 April 2005 
Netherlands All substances included in Table I 19 May 2000 
Nigeriaa All substances included in Tables I and II 28 February 2000 
Oman All substances included in Tables I and II 16 April 2007 
Pakistana Acetic anhydride, acetone, ephedrine, potassium 
permanganate and pseudoephedrine 
12 November 2001 
Paraguaya All substances included in Tables I and II 3 February 2000 
Perua Acetic anhydride, acetone, ephedrine, ergometrine, 
ergotamine, ethyl ether, hydrochloric acid, lysergic 
acid, methyl ethyl ketone, norephedrine, potassium 
permanganate, pseudoephedrine, sulphuric acid and 
toluene 
27 September 1999 
Philippinesa All substances included in Tables I and II 16 April 1999 
Poland All substances included in Table I 19 May 2000 
Portugal All substances included in Table I 19 May 2000 
Republic of Korea All substances included in Table I and acetone 3 June 2008 
Republic of Moldovaa All substances included in Tables I and II 29 December 1998 
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Notifying Government 
Substances to which pre-export notification requirement 
applies 
Date of communication to Governments 
by the Secretary-General 
Romaniaa  All substances included in Table I  19 May 2000 
Russian Federationa Acetic anhydride, ephedrine, ergometrine, 
ergotamine, 3,4-methylenedioxyphenyl-2-
propanone, norephedrine, 1-phenyl-2-propanone, 
potassium permanganate, pseudoephedrine and all 
substances included in Table II 
21 February 2000 
Saudi Arabiaa All substances included in Tables I and II 18 October 1998 
Singapore All substances included in Table I 5 May 2000 
Slovakia All substances included in Table I 19 May 2000 
Slovenia All substances included in Table I 19 May 2000 
South Africaa All substances included in Table I, anthranilic acid 11 August 1999 
Spain All substances included in Table I 19 May 2000 
Sri Lanka All substances included in Table I 19 November 1999 
Sweden All substances included in Table I 19 May 2000 
Tajikistana All substances included in Tables I and II 7 February 2000 
Turkeya All substances included in Tables I and II 2 November 1995 
United Arab Emiratesa All substances included in Tables I and II 26 September 1995 
United Kingdom All substances included in Table I 19 May 2000 
United Republic of 
Tanzaniaa 
All substances included in Tables I and II  10 December 2002 
United States of America Acetic anhydride, ephedrine and pseudoephedrine 2 June 1995 and  
19 January 2001 
Venezuela (Bolivarian 
Republic of)a 
All substances included in Tables I and II 27 March 2000 
European Union (on behalf 
of all its States members)e 
All substances included in Table I 19 May 2000 
 
Notes: The names of territories are in italics. 
 a The Secretary-General has informed all Governments of the request of the notifying Government to 
receive a pre-export notification for substances listed in Table II of the 1988 Convention as well. 
 b Not yet notified by the Secretary-General as, in a subsequent communication, the Government of 
Belarus requested the Secretary-General to suspend such notification until a national mechanism to 
receive and process pre-export notifications is established.  
 c Since 31 March 2009, “Plurinational State of Bolivia” has replaced “Bolivia” as the short form used 
in the United Nations. 
 d Not yet notified by the Secretary-General. 
 e Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, 
Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, 
Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and United Kingdom of Great Britain and 
Northern Ireland. 
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 Annex VII 
 
 
  Substances in Tables I and II of the 1988 Convention 
 
 
Table I Table II 
Acetic anhydride Acetone 
N-Acetylanthranilic acid Anthranilic acid 
Ephedrine Ethyl ether 
Ergometrine Hydrochloric acida 
Ergotamine Methyl ethyl ketone 
Isosafrole Phenylacetic acid 
Lysergic acid Piperidine 
3,4-Methylenedioxyphenyl-2-propanone Sulphuric acida 
Norephedrine  Toluene 
1-Phenyl-2-propanone  
Piperonal  
Potassium permanganate  
Pseudoephedrine  
Safrole  
  
  
The salts of the substances in this Table 
whenever the existence of such salts is 
possible. 
The salts of the substances in this Table 
whenever the existence of such salts is 
possible. 
 
 
 a The salts of hydrochloric acid and sulphuric acid are specifically excluded from Table II.  
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Annex VIII 
 
 
  Use of scheduled substances in the illicit manufacture of 
narcotic drugs and psychotropic substances 
 
 
 The use of scheduled substances in the illicit manufacture of narcotic drugs 
and psychotropic substances, depicted in figures A.I-A.IV below, represents classic 
production and manufacturing methods. The extraction of cocaine from coca leaf 
and the purification of coca paste and the crude base products of cocaine and heroin 
require solvents, acids and bases. A wide range of such chemicals has been used at 
all stages of drug production. 
Figure A.I 
  Illicit manufacture of cocaine and heroin: scheduled substances and the 
approximate quantities of them required for the illicit manufacture of 
100 kilograms of cocaine or heroin hydrochloride 
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Figure A.II 
Illicit manufacture of amphetamine and methamphetamine: scheduled 
substances and the approximate quantities of them required for the illicit 
manufacture of 100 kilograms of amphetamine sulphate and 
methamphetamine hydrochloride 
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Figure A.III 
Illicit manufacture of methylenedioxymethamphetamine and related drugs: 
scheduled substances and the approximate quantities of them required for the 
manufacture of 100 litres of 3,4-methylenedioxyphenyl-2-propanone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Approximately 250 litres of 3,4-methylenedioxyphenyl-2-propanone (3,4-MDP-2-P) are required to 
manufacture 100 kg of 3,4-methylenedioxyamphetamine (MDA) hydrochloride; and 125 litres of 
3,4-MDP-2-P are required to manufacture 100 kg of methylenedioxymethamphetamine (MDMA) or 
3,4-methylenedioxyethylamphetamine. 
 a Including safrole in the form of sassafras oil. 
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Figure A.IV 
Illicit manufacture of lysergic acid diethylamide (LSD), methaqualone and 
phencyclidine: scheduled substances and the approximate quantities of them 
required for the illicit manufacture of 1 kilogram of LSD and 100 kilograms of 
methaqualone and phencyclidine 
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Annex IX 
 
 
  Licit uses of the substances in Tables I and II of the  
1988 Convention 
 
 
 Knowledge of the most common licit uses of substances in Tables I and II of 
the United Nations Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988, including the processes and end products in which 
the substances may be used, is essential to the verification of the legitimacy of 
orders or shipments. The most common licit uses of those substances reported to the 
International Narcotics Control Board are as follows: 
Substance Licit uses 
Acetic anhydride Acetylating and dehydrating agent used in the chemical 
and pharmaceutical industries for the manufacture of 
cellulose acetate, for textile sizing agents and cold 
bleaching activators, for polishing metals and for the 
production of brake fluids, dyes and explosives 
Acetone Common solvent in the chemical and pharmaceutical 
industries; used in the production of lubricating oils and 
as intermediary in the manufacture of chloroform and in 
the manufacture of plastics, paints, varnishes and 
cosmetics 
N-Acetylanthranilic acid Used in the manufacture of pharmaceuticals, plastics and 
fine chemicals 
Anthranilic acid Chemical intermediate used in the manufacture of dyes, 
pharmaceuticals and perfumes; also used in the 
preparation of bird and insect repellents.  
Ephedrine Used in the manufacture of bronchodilators (cough 
medicines) 
Ergometrine Used in the treatment of migraine and as oxytocic in 
obstetrics 
Ergotamine Used in the treatment of migraine and as oxytocic in 
obstetrics 
Ethyl ether Commonly used solvent in chemical laboratories and in 
the chemical and pharmaceutical industries: mainly used 
as an extractant for fats, oils, waxes and resins; used for 
the manufacture of munitions, plastics, perfumes; used in 
medicine as a general anaesthetic. 
Hydrochloric acid  Used in the production of chlorides and hydrochlorides; 
used for the neutralization of basic systems; used as a 
catalyst and solvent in organic synthesis 
Isosafrole Used in the manufacture of piperonal; used to modify 
oriental perfumes; used to strengthen soap perfumes; 
used in small quantities, together with methyl salicylate, 
in root beer and sarsaparilla flavours; also used as a 
pesticide 
Lysergic acid Used in organic synthesis 
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Substance Licit uses 
3,4-Methylenedioxy-phenyl-2-
propanone 
Used in the manufacture of piperonal and other perfume 
components 
Methyl ethyl ketone Common solvent; used in the manufacture of coatings, 
solvents, degreasing agents, lacquers, resins and 
smokeless powders 
Norephedrine Used in the manufacture of nasal decongestants and 
appetite suppressants 
Phenylacetic acid  Used in the chemical and pharmaceutical industries for 
the manufacture of phenylacetate esters, amphetamine 
and some derivatives; used for the synthesis of 
penicillins; used in fragrance applications and cleaning 
solutions 
1-Phenyl-2-propanone Used in the chemical and pharmaceutical industries for 
the manufacture of amphetamine, methamphetamine and 
some derivatives; used for the synthesis of 
propylhexedrine 
Piperidine Commonly used solvent and reagent in chemical 
laboratories and in the chemical and pharmaceutical 
industries; also used in the manufacture of rubber 
products and plastics 
Piperonal Used in perfumery; used in cherry and vanilla flavours; 
used in organic synthesis and as a component for 
mosquito repellent 
Potassium permanganate Important reagent in analytical and synthetic organic 
chemistry; used in bleaching applications, disinfectants, 
antibacterials and antifungal agents; used in water 
purification 
Pseudoephedrine Used in the manufacture of bronchodilators and nasal 
decongestants 
Safrole Used in perfumery, for example in the manufacture of 
piperonal, denaturing fats in soap manufacture 
Sulphuric acid Used in the production of sulphates; as an acidic 
oxidizer; used as a dehydrating and purifying agent; used 
for the neutralization of alkaline solutions; used as a 
catalyst in organic synthesis; used in the manufacture of 
fertilizers, explosives, dyestuffs, paper; used as a 
component of drain and metal cleaners, anti-rust 
compounds and automobile battery fluids 
Toluene Industrial solvent; used in the manufacture of explosives, 
dyes, coatings and other organic substances and as a 
gasoline additive 
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  Treaty provisions for the control of substances frequently 
used in the illicit manufacture of narcotic drugs and 
psychotropic substances 
 
 
1. Article 2, paragraph 8, of the Single Convention on Narcotic Drugs of 1961a 
provides as follows: 
 “The Parties shall use their best endeavours to apply to substances which 
do not fall under this Convention, but which may be used in the illicit 
manufacture of drugs, such measures of supervision as may be practicable.” 
2. Article 2, paragraph 9, of the Convention on Psychotropic Substances of 1971b 
provides as follows: 
  “The Parties shall use their best endeavours to apply to substances which 
do not fall under this Convention, but which may be used in the illicit 
manufacture of psychotropic substances, such measures of supervision as may 
be practicable.” 
3. Article 12 of the United Nations Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988c contains provisions for the following: 
 (a) General obligation for parties to take measures to prevent diversion of 
the substances in Table I and Table II of the 1988 Convention and to cooperate with 
each other to that end (para. 1); 
 (b) Mechanism for amending the scope of control (paras. 2-7); 
 (c) Requirement to take appropriate measures to monitor manufacture and 
distribution, to which end parties may: control persons and enterprises; control 
establishments and premises under licence; require permits for such operations; and 
prevent accumulation of substances in Tables I and II (para. 8); 
 (d) Obligation to monitor international trade in order to identify suspicious 
transactions; to provide for seizures; to notify the authorities of the parties 
concerned in case of suspicious transactions; to require proper labelling and 
documentation; and to ensure maintenance of such documents for at least two years 
(para. 9); 
 (e) Mechanism for advance notice of exports of substances in Table I, upon 
request (para. 10); 
 (f) Confidentiality of information (para. 11); 
 (g) Reporting by parties to the International Narcotics Control Board 
(para. 12); 
 (h) Report of the Board to the Commission on Narcotic Drugs (para. 13); 
 (i) Non-applicability of the provisions of article 12 to certain preparations 
(para. 14). 
 
__________________ 
 a United Nations, Treaty Series, vol. 520, No. 7515. 
 b Ibid., vol. 1019, No. 14956. 
 c Ibid., vol. 1582, No. 27627. 
  
About the International Narcotics Control Board 
  
The International Narcotics Control Board (INCB) is an independent and quasi-judicial control organ, established by 
treaty, for monitoring the implementation of the international drug control treaties. It had predecessors under the 
former drug control treaties as far back as the time of the League of Nations. 
  
Composition 
  
 INCB consists of 13 members who are elected by the Economic and Social Council and who serve in their 
personal capacity, not as Government representatives. Three members with medical, pharmacological or 
pharmaceutical experience are elected from a list of persons nominated by the World Health Organization (WHO) and 
10 members are elected from a list of persons nominated by Governments. Members of the Board are persons who, by 
their competence, impartiality and disinterestedness, command general confidence. The Council, in consultation with 
INCB, makes all arrangements necessary to ensure the full technical independence of the Board in carrying out its 
functions. INCB has a secretariat that assists it in the exercise of its treaty-related functions. The INCB secretariat is an 
administrative entity of the United Nations Office on Drugs and Crime, but it reports solely to the Board on matters of 
substance. INCB closely collaborates with the Office in the framework of arrangements approved by the Council in its 
resolution 1991/48. INCB also cooperates with other international bodies concerned with drug control, including not 
only the Council and its Commission on Narcotic Drugs, but also the relevant specialized agencies of the United 
Nations, particularly WHO. It also cooperates with bodies outside the United Nations system, especially the 
International Criminal Police Organization (INTERPOL) and the World Customs Organization. 
  
Functions 
  
 The functions of INCB are laid down in the following treaties: the Single Convention on Narcotic Drugs of 1961 
as amended by the 1972 Protocol; the Convention on Psychotropic Substances of 1971; and the United Nations 
Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988. Broadly speaking, INCB 
deals with the following: 
 (a) As regards the licit manufacture of, trade in and use of drugs, INCB endeavours, in cooperation with 
Governments, to ensure that adequate supplies of drugs are available for medical and scientific uses and that the 
diversion of drugs from licit sources to illicit channels does not occur. INCB also monitors Governments’ control over 
chemicals used in the illicit manufacture of drugs and assists them in preventing the diversion of those chemicals into 
the illicit traffic; 
 (b) As regards the illicit manufacture of, trafficking in and use of drugs, INCB identifies weaknesses in 
national and international control systems and contributes to correcting such situations. INCB is also responsible for 
assessing chemicals used in the illicit manufacture of drugs, in order to determine whether they should be placed under 
international control. 
 In the discharge of its responsibilities, INCB: 
 (a) Administers a system of estimates for narcotic drugs and a voluntary assessment system for psychotropic 
substances and monitors licit activities involving drugs through a statistical returns system, with a view to assisting 
Governments in achieving, inter alia, a balance between supply and demand; 
 (b)  Monitors and promotes measures taken by Governments to prevent the diversion of substances frequently 
used in the illicit manufacture of narcotic drugs and psychotropic substances and assesses such substances to determine 
whether there is a need for changes in the scope of control of Tables I and II of the 1988 Convention; 
   
 
 (c) Analyses information provided by Governments, United Nations bodies, specialized agencies or other 
competent international organizations, with a view to ensuring that the provisions of the international drug control 
treaties are adequately carried out by Governments, and recommends remedial measures; 
 (d) Maintains a permanent dialogue with Governments to assist them in complying with their obligations under 
the international drug control treaties and, to that end, recommends, where appropriate, technical or financial assistance 
to be provided. 
 INCB is called upon to ask for explanations in the event of apparent violations of the treaties, to propose 
appropriate remedial measures to Governments that are not fully applying the provisions of the treaties or are 
encountering difficulties in applying them and, where necessary, to assist Governments in overcoming such difficulties. 
If, however, INCB notes that the measures necessary to remedy a serious situation have not been taken, it may call the 
matter to the attention of the parties concerned, the Commission on Narcotic Drugs and the Economic and Social 
Council. As a last resort, the treaties empower INCB to recommend to parties that they stop importing drugs from a 
defaulting country, exporting drugs to it or both. In all cases, INCB acts in close cooperation with Governments. 
 INCB assists national administrations in meeting their obligations under the conventions. To that end, it proposes 
and participates in regional training seminars and programmes for drug control administrators. 
  
Reports 
  
 The international drug control treaties require INCB to prepare an annual report on its work. The annual report 
contains an analysis of the drug control situation worldwide so that Governments are kept aware of existing and 
potential situations that may endanger the objectives of the international drug control treaties. INCB draws the 
attention of Governments to gaps and weaknesses in national control and in treaty compliance; it also makes 
suggestions and recommendations for improvements at both the national and international levels. The annual report is 
based on information provided by Governments to INCB, United Nations entities and other organizations. It also uses 
information provided through other international organizations, such as INTERPOL and the World Customs 
Organization, as well as regional organizations. 
 The annual report of INCB is supplemented by detailed technical reports. They contain data on the licit 
movement of narcotic drugs and psychotropic substances required for medical and scientific purposes, together with an 
analysis of those data by INCB. Those data are required for the proper functioning of the system of control over the 
licit movement of narcotic drugs and psychotropic substances, including preventing their diversion to illicit channels. 
Moreover, under the provisions of article 12 of the 1988 Convention, INCB reports annually to the Commission on 
Narcotic Drugs on the implementation of that article. That report, which gives an account of the results of the 
monitoring of precursors and of the chemicals frequently used in the illicit manufacture of narcotic drugs and 
psychotropic substances, is also published as a supplement to the annual report. 
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